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ABSTRACT
Tissue-Specific Matrix Control of Cell Cohesion and Migration Signaling Complexes
Tristen Victoria Tellman, B.S.
Advisory Professor: Mary C. Farach-Carson
The extracellular matrix (ECM) is a complex, interconnected network of three major
constituents: collagens, glycoproteins, and proteoglycans, along with their enzyme modifiers.
Within this network and beyond the structural role, each ECM molecule contributes a contextspecific signal that influences cellular fate and behavior. Among these behaviors, cellular
migration provides an essential function in developing tissues, wound healing, and cancer cell
metastasis. Using two glandular organs, the normal salivary gland and the cancerous
prostate, this dissertation describes the tissue-specific composition of two ECM signaling
complexes (type I hemidesmosomes and the perlecan-semaphorin 3A-plexin A1-neuropilin-1
(PSPN) complex) and translates this knowledge into viable solutions for both tissue
engineering and cancer metastasis applications. Database (Matrisome/FANTOM5) and twodimensional and three-dimensional cell culture analysis identified collagen XVII and the
heparan sulfate proteoglycan perlecan/HSPG2 as two key ECM components controlling cell
cohesion and migration in salivary gland and prostate cancer (PCa) epithelial cells,
respectively. These two matrix proteins maintain key roles in the induction of migratory
signaling events through their respective signaling complexes. In the first study, using
combined biochemical and unbiased computational approaches, we identified key signatures
promoter-level gene expression of 274 core ECM proteins in a tissue-specific manner. In the
second study, collagen XVII in type I hemidesmosomes was studied in the context of migration
and complex microstructure organization of salivary stem/progenitor cells in salivary
morphogenesis. In the third study, perlecan, in the newly identified PSPN complex, was found
to control the cohesion-dyscohesion axis of PCa tumoroids, indicative of its role in controlling
PCa metastasis. Taken together, the discoveries from this work can be leveraged to create
vii

new treatment options that control cell behavior for those patients with damaged glands
experiencing xerostomia/dry mouth and in need of salivary gland restoration or patients with
PCa metastases.
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CHAPTER 1 INTRODUCTION
The Extracellular Matrix
The extracellular matrix (ECM) is a large, acellular network of molecules that function in
various roles during tissue development and homeostasis. This large group of proteins can
be broadly broken down into the three categories of collagens, glycoproteins, and
proteoglycans, each with distinct structural features. Collagens, one of the most abundant
classes of ECM proteins in humans, are triple-helical proteins that are comprised of three
parallel polypeptide helical strands coiled to form a super triple-helical structure. These three
strands combine to form 28 different types of collagen that can be fibrillar, network-forming,
fibril-associated with interrupted triple-helices, membrane-associated with interrupted triplehelices, and multiplexins [1,2]. Fibrillar collagens are the most abundant collagen type, playing
a role in tissue architecture, shape, and mechanical properties. These collagens represent
the major collagen type in connective tissues and organize into aggregates that present a
banded pattern at the ultrastructural level. Collagens of this subclass have a large, continuous
triple-helix bordered by the N- and C-terminal extension, where the C-terminal extension is
conserved among members of this family and the N-terminal extension is varied [3]. Fibrilassociated collagens with interrupted triple-helices are those collagens that interact with fibrils
to form more complex structures. These collagens contain more than one triple-helical domain
separated by non-triple-helical segments. Unlike their fibrillar counterparts, these collagens
are not secreted in a pro-collagen form and do not require proteolytic processing [4]. Each of
the network-forming collagens is capable of creating a unique networking structure, largely
characterized by their ability to form linear and lateral associations. These network-forming
collagens can aid in cell anchorage, serve as molecular filters, and even provide permeable
barriers in developing embryos [5]. Membrane-associated collagens with interrupted triple1

helices are structurally characterized by their non-collagenous intracellular domain, a singlespan transmembrane region, and a flexible rod-like ectodomain. These collagens serve a
primary role in cell-cell and cell-ECM adhesions through their distinct tissue distribution and
abundance [6]. The multiplexin subclass of collagens is comprised of only two collagens,
collagen XV and XVIII. These collagens are nonfibrillar, multidomain structures with
alternating triple-helical collagenous and non-collagenous domains. Both of these collagens
are widely distributed throughout the body but only collagen XVIII is considered an integral
part of the basement membrane, binding to perlecan, laminins, and nidogens [6,7].

Glycoproteins, the next major category of ECM proteins, are the largest group by far, being
comprised of 195 out of the 274 defined core matrisome genes [2]. These proteins are
characterized by their covalently linked glycans attached to a polypeptide backbone. The most
common types of linkage in glycoproteins are the N- and O-linked types where N-linked
oligosaccharides are attached to an asparagine residue and O-linked oligosaccharides are
attached to serine or threonine residues [8]. These types of glycoproteins include fibronectin,
laminins, and nidogens among many others. This diversity in protein type and structure lends
itself to a wide variety of functions, both structurally and in cell signaling, that the glycoprotein
family can provide. Proteoglycans, another subclass of glycoproteins, are more specifically
defined by their covalently bound glycosaminoglycan (GAG) chains that can be chondroitin
sulfate, heparin/heparan sulfate, dermatan sulfate, or keratan sulfate [9]. This group of
proteins makes up only 35 of the 274 core matrisome genes due to the specific nature of their
glycan structure [2]. These large, evolutionarily conserved proteins can be extracellular,
transmembrane, or bound inside of the cell in secretory granules or the nucleus [10]. The
large, branched GAG chains of these molecules often serve as reservoirs for ligands and for
release to cell surface receptors.
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The ECM in Developing Glands
Glandular tissues maintain a common tissue organization composed of a single layer of
epithelial cells lined on their basal side by basement membrane. This organization maintains
apical-basal polarity and allows for the formation of tight junctions, leading to ability of these
structures to maintain fluid-filled lumen through which fluids pass into the duct and to their
final destination. To maintain homeostasis in glandular tissues, this cell-matrix interaction
must be stabilized and maintained. In diseases of the gland, this interaction is often
compromised, either through breakdown of the basement membrane or through aberrant
growth of the epithelial cell layer, resulting in modification and invasion of surrounding areas.

Salivary Gland Development

In humans, there are four major types human salivary gland, the submandibular (SMG),
sublingual, parotid (PG), and an array of minor salivary glands [11]. The major and minor
salivary glands differ slightly in their interactions with surrounding matrices, where major
glands are encapsulated and minor glands are merely surrounded by connective tissue.
Additionally, each major gland contains a differing ratio of serous, mucinous, and seromucous
acini lending to their differential salivary secretions. The PG is largely serous, making a watery
saliva, while the SMG and sublingual glands contain a mixture of serous and mucous acini,
though the SMG is primarily composed of serous acini (ref). Minor glands produce a near
constant flow of saliva that is predominantly mucous in character [12]. The ductal structures
leading from acini to the oral cavity can also be stratified into three categories: intercalated,
striated, and excretory. As before, each of these ducts maintains a specific function, with
intercalated ducts emptying to striated ducts then to the excretory ducts, a process through
which saliva becomes hypotonic [13]. Development of the salivary gland is directed by
3

coordinated signaling through molecular and mechanical events. Salivary glands develop via
branching morphogenesis, taking around 22 gestational weeks to go from bud to fully
functional glands. The fully mature gland is comprised of multiple cells types including those
of the acinus, duct, myoepithelium, neurons, lymphatic cells, and endothelial cells derived
from the ectoderm [14].

Several ECM proteins have been studied in the context of salivary gland development, where
fibronectin, laminin, perlecan, and collagen all play essential roles in proper branching
morphogenesis and maintenance of homeostatic architecture [15]. Fibronectin impacts cleft
formation and maintenance as well as cell proliferation. Knockdown of fibronectin in the
developing gland decreases branching that can be rescued by exogenous addition of
fibronectin [16]. Laminin 111, 211, 332A, 332B, 411, and 511 have been extensively studied
in this context, each lending specific cues to the developing gland [17]. Studies of laminin 111
in conjunction with fibroblast growth factor 2 in the developing mouse SMG show that this
ECM component is crucial to the development and retention of mature, aquaporin 5-positive
salivary organoids [18]. Interestingly, the laminin α1 chain is specifically localized in acinar
structures and intercalated ducts of the mature gland, again demonstrating its essential role
in acinar structural stability [19]. In mouse studies of the laminin α5 chain in the SMG it has
been shown that as the gland branches, α5 expression increases while α1 decreases.
Knockout of α5 delays clefting of the developing gland and effects cellular organizations as
well as lumen formation [20]. Perlecan expression effects the ability of salivary cells to
organize complex structures and is expressed in the very early blastocyst stage during
embryonic development to serve as a reservoir for growth factors [21–23]. Various collagens
also play a role in the development of the salivary gland. Treatment of a developing SMG with
collagenase inhibits branching morphogenesis, demonstrating the essential role of intact
collagen [24]. More specifically, collagens III and IV have been shown in various studies to
4

influence branching morphogenesis and drive the differentiation of acinar cells [25,26]. While
we mention only a few of the many matrix proteins that influence the developing salivary gland,
it is important to remember that this process is a coordinated effort that relies heavily on the
exact timing of expression and release of matrix proteins and growth factors to stimulate the
necessary cues.

Prostate Development

Similar to the development of the salivary gland, the prostate gland, another excretory gland,
undergoes five major stages of development: pre-bud, initial budding, bud elongation &
branching, morphogenesis, and ductal canalization [27]. During its development, the prostate
relies heavily upon androgens, signaling through the androgen receptor, and on cues from
the surrounding mesenchyme [28]. The resulting structure, though internally branched, is
overall smooth and takes on a somewhat chestnut shaped. In studies of mice and rats, each
lobe of the prostate undergoes a unique branching morphogenesis [29].

Unfortunately, there is not much literature on the influence of the ECM in prostate glandular
development. It has been shown that the androgen-dependent process of budding is closely
tied to changes in heparan sulfate patterns related to the relative expression of the heparan
sulfate-modifying enzyme sulfatase 1, where high sulfatase 1 expression partially inhibited
ductal morphogenesis [30]. In a study on the effects of tenascin-C knockout in the
development of mouse prostate, the absence of tenascin-C decreased androgen receptorpositive cells and increased the number of epithelial cell protruding into the ductal lumens.
This study suggests that tenascin-C is involved in cytodifferentiation, morphogenesis, and
androgen receptor expression essential to normal prostate gland development [31]. Matrix
metalloproteinase (MMP) -2, another ECM modifying enzyme, has been studied in
5

conjunction with matrix MMP-9 to determine their influence on normal prostate development.
In this study, the authors conclude the essentiality of MMP-2 for epithelial morphogenesis and
inability of MMP-9 to recover the glandular phenotype [32].

Cell-Cell and Cell-Matrix Adhesions
Cell-cell and cell-matrix adhesions decisions govern the patterning of hierarchical structures
in developing glands such as the salivary gland and prostate [33]. Cell-cell adhesions are
those interactions which attach one cell to a neighboring cell to maintain epithelial cell layers.
Major types of cell-cell adhesions include adherens junctions, desmosomes, tight junctions,
and gap junctions. While there are many interactions that exist between cells and their
surrounding matrices, for the purpose of this dissertation the focus will remain on
hemidesmosomes, as this is a major focus in chapter 3 of this dissertation.

Adherens Junctions

Adherens junction are comprised of members of the cadherin and nectin families, both of
which span the plasma membrane [34]. These junctions preclude the assembly of the more
apical tight junctions, comprised of a large number of proteins [34]. Both of these junctions
associate with the actin cytoskeleton and can influence signaling events and the selective
permeability between cells [35]. Early in salivary gland development, E-cadherin and βcatenin, members of the calcium-dependent adherens junction, play an essential role in
organization and differentiation [33,36]. In a study of E-cadherin knockout in the developing
prostates of mice, the loss of these adherens junctions disrupts the orientation of spindle
poles, leading to lack of organization in the lumen [37].

6

Tight Junctions

Tight junction proteins present in salivary glands include claudins, occludins, junctional
adhesion molecules, and the cytosolic zonula occludens. Maintenance of tight junctions is
essential to the functional fluid secretory abilities of salivary glands. Claudin-1 is found in
ductal, endothelial, and serous cells, while claudins-2, -3, -4, and junctional adhesion
molecule-A are expressed in both acinar and ductal cells. Interestingly, claudin-5 remains
specific to endothelial cells. Occludin and zonula occluden-1 were expressed in the acinar,
ductal, and endothelial cells of fully formed salivary glands [38].

Hemidesmosomes

Hemidesmosomes are responsible for anchoring basal epithelial cells to the basement
membrane. Hemidesmosomes can be defined as either type I or type II based on their
molecular composition. Type I hemidesmosomes are composed of integrin α6β4, plectin
isoform 1a, laminin-332, collagen XVII, dystonin, and CD151. Type II hemidesmosomes are
predominantly found in simple epithelia and consist of integrin α6β4 and plectin [39].
Hemidesmosomes serve a crucial function in the maintenance of epithelial integrity, where
mutations resulting in instability of the protein complex can lead to epidermolysis bullosa, or
butterfly skin disease. Loss of α6β4/laminin 332 interactions in type I hemidesmosomes of the
salivary gland is believed to lead to acinar cell anoikis [19,40]. In prostate cancer, carcinomas
lack hemidesmosomal structures, suggesting that hemidesmosomes may play a role in the
ability of prostate cancer progression and metastasis [41].

7

CHAPTER 2 A SYSTEMIC ANALYSIS OF THE EXTRACELLULAR
MATRIX IN HUMAN BIOLOGY
This chapter was modified from Tellman, T.V., Dede, M., Aggarwal, V.A., Naba, A., FarachCarson, M.C. Systematic Analysis of Actively Transcribed Core Matrisome Genes Across
Tissues and Cell Phenotypes; manuscript currently under revision in Matrix Biology, 2022.

1. Introduction
The ECM is a highly dynamic, well-organized acellular network of biomolecules that are
assembled in a tissue-specific manner. The ECM lends overall function and form to tissues,
aiding in the fine-tuning of cellular phenotype, adhesion, wound repair, mechanical
transduction, development, differentiation, and, when disrupted, disease and dysregulated
repair [42–45]. In the seminal matrisome paper published by the Hynes group in 2011, the
ECM and its associated proteins were divided into two major groups (core matrisome and
matrix-associated) based on in silico definitions [46,47]. The core matrisome is divided further
into three major categories of ECM: proteoglycans, glycoproteins, and collagens [47–51].
Briefly, these categories are defined by major features of the group wherein glycoproteins are
macromolecules with covalently linked carbohydrates, or glycans, of varying lengths and
degrees of branching, attached to a protein core. Proteoglycans, a subclass of glycoproteins,
contain specific linear GAGs attached to a protein core with repeating disaccharides that
define them as chondroitin sulfate, heparin/heparan sulfate, dermatan sulfate, or keratan
sulfate [9,52]. Collagens are the most abundant category, by percentage, of the ECM, and
are characterized by their unique right-handed three parallel polypeptide strand helical
structure that can be either continuous or interrupted [53]. These definitions, as well as
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consensus structural elements and structural domain elements, are what helped define the
original annotated matrisome.

While this original analysis provided a first-of-its-kind definition of the ECM and affiliated
components, there remained the intriguing opportunity to overlay these individual ECM
components with their relative tissue- and cell-level distributions. Several groups have
conducted analysis on the matrisome using datasets comprised of single-cell, RNAsequencing, and gene expression data from the Genotype-Tissue Expression, The Cancer
Genome Atlas program, and the Gene Expression Omnibus, to name a few. These papers
looked at the matrisome in tissue, age, sex, disease, and as signatures for cell typing in
developing embryos, though none are able to provide a comprehensive overview of the
matrisome at the promoter level in homeostatic tissues [54,55].

The SSTAR (Semantic catalog of Samples, Transcription initiation And Regulators) was
released through the RIKEN FANTOM5 project and contains relative read values of cap
analysis gene expression (CAGE) peak data as it relates to promoter-level activity, where
unique cap identifiers are read to generate tags per million reference values [56]. CAGE peak
is unique in its ability to capture the true active transcription of specific genes and providing
promoter-level expression at it relates to individual samples. This data set was a collaborative
effort from laboratories around the world, including our own, that submitted samples (tissues
and cells) from various organ systems. The comprehensive database contains transcription
start site data from ~1800 human samples, with detailed readings that can be interrogated
either by gene symbol or name (https://fantom.gsc.riken.jp/5/sstar/Main_Page). We combined
the information in the matrisome and FANTOM5 database to reveal the complexity and
specificity of the components of the matrisome in the human body. Here we describe for the
first time this powerful analysis and discuss examples of the relationships that can be
9

observed through correlation and clustering analysis of ECM-encoding genes and tissue/cell
samples.

2. Results and Interpretation
2.1 Data reduction produced a data matrix of 261 genes with 511 samples.
The original data set for this analysis was derived from cross-referencing the matrisome [49]
and the FANTOM5 SSTAR databases [56] resulting in a data matrix of 274 core matrisome
genes x 891 tissue/cell samples as shown in Figure 2.1. The data was divided further into
three major categories: proteoglycans, glycoproteins, and collagens containing 36, 182, and
43 genes, respectively. Matrisome genes not included in this analysis are AMELY, BSPH1,
CDCP2, DSPP, NTN5, OTOG, OTOL1, POMZP3, SSPO, TECTA, ZP4, ZPLD1, and COL6A6
because the corresponding SSTAR data was missing from the FANTOM5 database. The final
matrix promoter-level gene expression dataset included 261 ECM-encoding genes that were
analyzed. We note here that AGRN was re-categorized from the original matrisome definition
to a proteoglycan, consistent with what is now known about the protein. [50] COLXVIII and
COLXV are considered proteoglycans, but for this analysis were left in the collagen category,
consistent with the original matrisome assignments.

The data set was filtered further to remove immortalized cells lines, diseased tissues,
experimentally treated primary cells, and samples with missing values. The samples were
categorized manually into systems based on their primary affiliation. Primary affiliation here is
defined as the system in which a cell or tissue type is most closely phenotypically, rather than
anatomically, related. The traditional physiological ten system nomenclature (cardiovascular,
nervous and sensory, digestive, respiratory, renal, reproductive, endocrine, immune,
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Figure 2.1 Workflows diagram of matrisome and FANTOM5 data reduction. Matrisome
genes were cross-referenced with the FANTOM5 CAGE peak data to create the
resulting analysis matrix. Further data reduction produced three major matrices with
manual system annotations for each sample.
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musculoskeletal, and integumentary system) did not fit the matrix promoter-level expression
data well (data not shown) so major tissue categories were defined for this analysis as:
cardiovascular, connective, digestive, endothelial, epithelial, immune, nervous, and
reproductive. As an example of how these categories fit the samples, adipocytes from the
breast were assigned to the connective tissue system. We note here that some samples may
adequately fit within multiple categories but are defined using additional information available
in the FANTOM5 database. Any samples that could not fit broadly into these major tissue
categories were eliminated from the analysis, resulting in a data set of 511 total samples.

2.2 Hierarchical clustering reveals unique tissue/cell-level clusters of gene
promoter activity.
Delineation of matrisome components into eight color-coded primary systems reveals unique
clusters of gene promoter activity. (Figure 2.2) Samples were hierarchically clustered as
described in the methods section where average linkage representing the Unweighted Pair
Group Method with Arithmetic Mean (UPGMA) and the Euclidean distance metric were used
to put like genes in a spatially related order, as indicated by hierarchical trees. (Figure 2.2)
From this clustering, we could determine relative trends in expression between certain
tissue/cell systems and their transcriptionally active ECM gene sets.

Unsurprisingly, the highly specialized proteoglycans KERA, IMPG2, OPTC, EPYC, PRG3,
IMPG1, and NYX showed little expression in almost all tissue/cell samples. HAPLN4,
SPOCK3, BCAN, NCAN, CHADL, and HAPLN2 make up a unique region that is localized at
higher levels to the nervous system. (Figure 2.2A) From the glycoproteins category,
fibrinogens FGB, FGA, and FGG comprise one of the most highly expressed gene sets and
are present in abundance in liver-derived samples, as expected. FNDC7 also is unique in this
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Figure 2.2 ClusterMaps of genes expressing proteoglycans, glycoproteins, and collagens
with annotated tissue systems. Proteoglycans (green, A), glycoproteins (red, B), and
collagens (blue, C) show unique patterns of expression through hierarchical clustering.
Relative expression of gene promoters within hierarchical clustering maps divided into
the previously defined matrisome categories.
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category for its near absence. (Figure 2.2B) Similar to what is seen for proteoglycans and
glycoproteins, the immune system showed an overall lack of expression of ECM-encoding
genes in the collagen data set. Distinct features in the collagen ClusterMap include COL17A1
expression in the epithelial system and COL6A1, COL6A2, COL1A1, and COL1A2
consistently expressed in both the connective and reproductive systems. (Figure 2.2C)
Z-scores were used to enable statistical comparisons across both genes and samples,
allowing for a more significant interpretation of the data. A positive (red) z-score indicates a
sample with a greater tags per million value, as compared to the mean, which correlates to a
more active promoter. A negative (blue) z-score indicates a sample that has a comparatively
smaller tags per million value, indicating a lower level of transcriptional activation.
Comparisons of z-scores across a gene, such as in Supplementary Figure 2.1, demonstrates
the statistical significance of the differences between samples/categories for a singular gene.
Z-scores calculated across samples, such as in Supplementary Figure 2.2, demonstrates the
relative distribution of transcriptionally active genes within a single sample.

To demonstrate this idea, the proteoglycan SRGN showed highest expression in the immune
system, as indicated by a highly positive (red) z-score, as compared to other systems.
(Supplementary Figure 2.1). Within the immune system, proteoglycans SPOCK2, HAPLN3,
and VCAN showed high levels of promoter-level expression as compared to other
proteoglycans (Supplementary Figure 2.2). In the glycoproteins group, SPARCL1, SPP1,
NELL2, IGFBP7, SPARC, IGFBP4, IGFBP5, and MGP were some of the most highly
transcribed genes in the nervous system, while LAMA3, LAMB3, and LAMC2 appeared as
major players in the epithelial system. (Supplementary Figure 2.3 & 2.4) In the category of
collagens, COL6A2 was the most highly transcribed collagen in the immune samples.
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(Supplementary Figure 2.6) Connective tissues and cells dominated production of this
matrisome category overall as compared to other systems. (Supplementary Figure 2.5)

2.3 Extracted cluster of interest from epithelial glycoproteins demonstrates
system-specific signatures that can unveil unforeseen expression patterns.
ClusterMaps and z-score analysis provided high-level detail of promoter-level gene
expression in all samples, so that relative trends could be assessed. Unique signatures were
revealed through these analyses by employing hierarchical clustering methods and statistical
analysis. Zooming in on one cluster of interest, as an example, revealed the relative active
transcription of genes encoding SPARCL1, SPP1, FGL2, EMILIN2, TNFAIP6, LAMA3,
LAMB3, and LAMC2 in epithelial samples. (Figure 2.3) LAMA3, LAMB3, LAMC2, and SPP1
were actively transcribed in epithelial samples extracted in this region, while FGL2 was not.
(Supplementary Figure 2.7)

While the relationship between LAMA3, LAMB3, and LAMC2 may seem obvious, other
members of this cluster can provide new information into previously unknown ECM
interactions in tissue/cell systems. In this example, the reason for this interaction in the dataset
is not immediately obvious. SPARCL1 is not well described in epithelial cell literature but is
found predominantly in neural tissues. In studies of SPARCL1 knockout mice, SPARCL1 was
found to modulate the dermal extracellular matrix via regulation of decorin levels and collagen
fibril assembly and functions to create intermediate states of adhesion in cells adjacent to the
epithelium [57]. SPP1 is a member of a subgroup of ECM proteins known as matricellular
proteins and is well-known for its involvement in the attachment of osteoclasts to the
mineralized bone matrix [58–60]. Interestingly, this analysis shows kidney epithelial cells as
one of the highest expressers of SPP1 (bone marrow is the other), consistent with the known
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Figure 2.3 Extracted cluster of interest from glycoproteins category reveals ECMencoding gene expression patterns in epithelial samples consistent with type I
hemidesmosomes. The extracted cluster contains SPARCL1, SPP1, FGL2, EMILIN2,
TNFAIP6, LAMA3, LAMB3, LAMC2.
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disease states associated with its mutation [61]. EMILIN2 acts in various ways throughout the
body, serving to induce angiogenesis in tumors via an epidermal growth factor receptordependent interaction [62], a pro-apoptotic role in [63], and an association with elastinmicrofibrils [64]. TNFAIP6 is a hyaluronate-binding protein closely related to CD44 and is
implicated in cell-cell and cell-matrix interactions during inflammation and tumorigenesis [65].
This protein may also play an essential role in the endometrium during the proliferative and
secretory phases of the menstrual cycle [66]. LAMA3, LAMB3, LAMC2 are subunits of laminin
332 (commonly known as laminin 5) in the epithelial basement membrane and play an integral
role in the formation of epithelial anchoring complexes including type I hemidesmosomes
[67,68]. Mutations in laminin 332 result in junctional epidermolysis bullosa-Herlitz. where, in
80% of cases, LAMB3 is affected [69]. While these proteins all play, in some capacity, a role
in epithelial cell anchorage and movement, their inter-connected relationship has not been
well defined. This analysis offers potential opportunities such as this one to uncover novel
interactions in ECM gene expression in unexpected tissue locations.

2.4 Correlation of matrisome components across tissue types
Correlation maps of the matrisome components across all tissue types can reveal unique
interactions that exist among these ECM molecules. Positive correlation (red) indicates
actively transcribed genes that behave in a similar way while negative correlation (blue)
indicates a high probability that these promoters exist independently of one another. Once
again, for this analysis the promoter-level expression data was divided into the three
matrisome categories of proteoglycans, glycoproteins, and collagens.

One interesting example of a positive correlation cluster in the proteoglycans group is among
OPTC, HAPLN2, IMPG2, NCAN, HAPLN4, and IMPG1. SRGN, only positively correlates with
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SPOCK2, HAPLN3, VCAN, PRG2, and PRG3, but is very negatively correlated with
molecules such as KERA and ASPN. (Figure 2.4A) Taken together, we can appreciate that
OPTC, HAPLN2, IMPG2, NCAN, HAPLN4, and IMPG1 are likely to be actively transcribed or
not transcribed in unison while negatively correlated SRGN and KERA would be less likely to
show similar connections in terms of promoter activity.

In the glycoproteins (Figure 2.4B), several correlation clusters stood out. One such cluster is
that of positive correlation between MATN4, KCP, RSPO1, AMELX, VWA3B, ZP1, IGSF10,
ELSPBP1, and FNDC8. In terms of negative correlation, we saw LRG1 whose expression is
strikingly anti-correlative with MATN3, RSPO4, LAMA1, and NTNG1, indicating these proteins
exhibit distinct behaviors from each other. (Supplementary Figure 2.8) LRG1 positively
correlated with MATN1, DMBT1, IGFBP1, VWA5B2, FGG, FGA, FGL1, FGB, TINAG, OIT2,
IGFALS, and VTN of the glycoprotein group, meaning it behaves in a similar manner to these
genes. (Supplementary Figure 2.9) FGL2 is also highly negatively correlated across the gene
set with MATN3, RSPO4, LAMA1, and NTNG1 but has some positive correlation with FBLN7,
VWDE, EMID1, NELL2, NTNG2, DDX26B, VWA5A, EMILIN2, COLQ, and TNFAIP6,
demonstrating the unique connections these ECM genes have. (Figure 2.4B & Supplementary
Figure 2.10)

From the positive cluster, MATN4 is one of the most ubiquitously expressed matrilins in the
human body and can found in epithelial, muscle, and nervous tissue as well as connective
tissue of internal organs [70,71]. MATN4 is crucial to maintaining the stability of articular
cartilage and interacts with various proteins to interconnect and stabilize these
macromolecular networks [72]. RSPO1 and AMELX also demonstrate unique roles in the
context of bone biology. RSPO1 has a bone anabolic effect, enhancing osteogenic markers
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Figure 2.4 Correlation of matrisome components in all tissue types. Proteoglycans (A),
glycoproteins (B), and collagens (C) show positive (red) and negative correlation (blue)
in promoter-level gene expression among various ECM constituents.
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and osteoprotegerin expression [73–76] as well as inducing and enhancing osteoblast
differentiation. AMELX is a protein secreted by ameloblasts to create tooth enamel [77]. KCP
is a potent paracrine enhancer of bone morphogenetic protein signaling in embryonic brain
and kidney samples [78], increases expression in human failing hearts [79], and aids in high
fat diet-induced obesity [78]. While there is no described role of KCP in bone, clustering of
this protein near other bone-affecting genes may be indicative of its ability to interact with and
signal in bone via its known bone morphogenetic protein signaling capacity. Additionally,
VWA3B is known for its effect, when mutated, in spinocerebellar ataxia [80], but has no known
role in bone, meaning it could face a similar fate as KCP within this bone-associated cluster.
Taken together, this analysis offers new insight into the potential role and relationship of these
proteins in a new context, the connective system.

ZP1, IGSF10, and ELSPBP1 all play crucial roles in human reproduction and clustered quite
readily with the lesser known FNDC8. ZP1 is expressed in the zona matrix of secondary and
antral follicles, ovulated oocytes, atretic follicles, and degenerating intravascular oocytes in
the female reproductive tract but also binds to capacitated spermatozoa and induces
acrosomal exocytosis [81]. IGSF10 mutations caused delayed puberty and hypogonadism
[42] while also exerting an important effect on breast cancer tumorigenesis [82]. ELSPBP1’s
known primary role is in its binding to already dead spermatozoa through epididymosomes
[83–86]. The roll of FNDC8 is not well described in literature, but hierarchical clustering in this
region could be indicative of its potential role in these areas where its positive correlation
indicates similar behaviors to locally clustered genes. Additionally, RSPO1 discussed in the
previous paragraph in the context of bone has two hormone-related roles in the body. RSPO1
can play a role in sex determination via Wnt4/β-catenin signaling during ovarian development
[87,88] and is required for normal development of the mammary gland [89].
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From the more negative glycoprotein cluster, LRG1 can function in signal transduction, cell
proliferation, migration, invasion, adhesion, survival, and apoptosis [90], roles which we
believe would make it more likely to positively correlate with other genes, making this negative
correlation even more striking. FGL2 however plays a primary role in the human immune
response as both a transmembrane and secreted form [91] so this negative correlation is
consistent with the reportedly small number of ECM molecules in the immune system [92].

Collagens traditionally have been thought of in the context of deposition by fibroblasts in
connective tissue, but this analysis provides insight into other cell and tissue types that
express collagen family members [93]. COL19A1 was unique in this dataset for its large
negative correlation with other members of the collagen family. (Figure 2.4C) Interestingly, in
mouse studies of COL19A1, mRNA can be found in all tissues except liver. In the adult mouse
however, COL19A1 mRNA was largely limited to the brain, which may explain its limited
correlation with other matrix components [94]. COL5A1, COL5A2, COL3A1, COL16A1,
COL1A1, and COL1A2 represent a positively correlated cluster in this family, indicative of
similar trends in promoter-level expression across the human body. COL5A1, COL5A2,
COL3A1, COL1A1, and COL1A2 are all fibril-forming collagens, while COL16A1 is a fibrilassociated collagen [51]. COL2A1 and COL3A1 are present in hyaline cartilage [95], COL1A1,
COL1A2, and COL3A1 are present in skin, while COL1A1, COL1A2, COL5A1, and COL5A2
are found in the cornea [96]. COL16A1 is a component of microfibrils containing fibrillin-1 in
skin alongside COL2A1, COL2A2, COL11A1, and COL11A2 [97]. While these collagens
appear to be associated with a broad array of tissues, this analysis offers a better look at how
these genes may interact at the promoter level across different tissues and cells where they
are actively transcribed. Taken together, these correlation analyses provide insight into the
relationships that may exist between ECM molecules at the promoter level. These positive
interactions, some of which are highlighted here, indicate promoters that are regulated in a
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similar manner, either being actively expressed or not expressed at the same time. Those
regions of negative correlation demonstrate the opposite interaction, where these promoters
act in opposing ways, with one being more active while the other is less active.

2.5 Extracted correlation map of proteoglycans in epithelial samples
Interesting patterns emerged when individual systems were extracted from the data and
correlation analyses were performed. In Figure 2.5, a correlation map was utilized to provide
insight into the expression relationships of proteoglycans in the epithelial system alone. Pairs
such as HAPLN2 and SPOCK3 and BCAN and HAPLN4 showed positive correlation between
genes. Larger clusters such as PRELP, FMOD and PODN; BGN, SRGN, DCN, and LUM;
CHADL, CHAD, and KERA also exhibited positive correlation where positive correlation (red)
means two gene promoters are likely to be expressed or not expressed at the same time.
OPTC and HSPG2, NYX and HAPLN3, and PODNL3, BCAN, and HAPLN4 were all
negatively correlated ECM-encoding genes. Taken together, these clustering regions indicate
regions of potentially interconnected behavior within the epithelial system, showing a systemspecific signature of gene behavior as opposed to a signature across all tissues/cells.

3. Discussion
Since it was published in 2011, the concept of the matrisome has remained a landmark work
in the field of matrix biology. For a decade, this analysis has provided major insight into the
ECM and shifted perceptions of links between structure and function. With the analysis
presented in this paper, we further establish the importance of the matrisome and offer a new
tool to interrogate the dynamics of human matrix biology at the gene promoter level. Our
analysis is unique in the comprehensive nature of the data from the FANTOM5 database as
it bypasses previous limitations of sample size and consistent experimental value acquisition.
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Figure 2.5 Correlation map of proteoglycans in the epithelial system.
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Additionally, this analysis examines specific promoter-level gene expression as opposed to
relative protein levels, indicative of what is being actively transcribed in cells and tissues. We
use the epithelial system as an example of how this information can be utilized and recognize
the value of this type of analysis in other systems as well. In this analysis, immortalized cell
lines were excluded from the data set due to existing research on the consequences of longterm cell culture. In the premier FANTOM5 paper, in-depth analysis on primary tissues/cells
versus immortalized cell lines shows that cell lines are far more likely to cluster with
themselves than with their derived tissue, indicative of the changes that occur in these cell
lineages over time [98]. As one specific example, studies have shown that cultured cells adapt
to their culture environment (e.g. plastic) to express non-physiological levels of ECM-binding
proteins such as the vitronectin receptor [99].

Correlation analysis of the ECM, as performed here, offers new unbiased insights into the
spacial relationship of these molecules and the potential networks that occur between their
active promoters. Such information can inform future interrogations of the roles of specific
ECM constituents in tissue formation, repair, and disease. We unveiled examples of wellestablished relationships among ECM components while also revealing potentially new
tissue-level interactions. While we focused here only on normal cells and tissues, this analysis
can provide insights into the potential involvement of various ECM molecules in human
developmental disorders. In analyses where tissue specimens were grouped, it is important
to recognize the potential limitations of correlation. Considering different tissue types
individually can reveal interactions that are more predominant in some systems over others,
explaining why certain mutations cause changes only in some tissues. This analysis can be
paired with results of mouse gene knockout strategies where often unpredicted phenotypes
are seen, examples of which include osteopontin and small leucine-rich proteoglycan
deficiencies [100,101].
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For this analysis we focused only on the interactions of the core matrisome, but the importance
of matrix-associated genes could be considered in future analyses. Many disease states are
associated not just with the matrix itself, but also with those molecules that interact with and
modify the matrix environment. For example, levels of various MMPs can support the
aggressive metastasis of various cancers [102,103]. Understanding how these modifiers
interact with the core matrisome in normal versus disease states could help identify new
targets for novel therapeutics to prevent dysregulation of proteins.

The matrix promoter-level expression dataset is a novel example of the power of large data
analytics and how it can inform more basic biological questions. This analysis is unique in its
specific interrogation of the promoter-level expression of the matrisome genes in the context
of normal, homeostatic tissues/cells and provides a unique opportunity to interrogate not just
context-specific expression but the relationships that may exist between these ECM genes.
This analysis provides insights that can be leveraged by both matrix biologists and clinicians
alike, as they seek to better understand the role of the ECM in human biology. We offer this
analysis to the matrix community at large as a resource for exploring the ECM and invite
members of the community to dig into this data further via the publicly available dataset that
can be found at http://farachcarsonwulab.com/. We believe this analysis functions as a living
document and this is simply the first iteration the matrix promoter-level gene expression data
set that we invite the community to explore and discuss as part of a larger conversation.

4. Experimental Procedures
Relative log expression (RLE) normalized SSTAR CAGE peak data files annotated with
hg19human reference genome assembly were downloaded from the FANTOM5 online
database for both phase 1 and 2 using FANTOM5 Table Extraction Tool (TET) found at
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https://fantom.gsc.riken.jp/5/tet/#!/search/hg19.cage_peak_counts_ann_decoded.osc.txt.gz.
The data set was filtered to exclude all cell lines, diseased tissues and samples with missing
values resulting in a total of 564 samples across all tissue systems (3 samples were removed
due to missing values (nan s). Genes encoding the core matrisome were extracted and utilized
for this analysis. First, the individual CAGE peak tags per million expression values of each
gene from the sample set were summed to obtain a gene level value. A pseudocount of 0.5
was added across the data set before logarithm transformation in order to prevent undefined
values where data values are zero prior to downstream statistical analysis. Samples were
further categorized into 8 core tissue systems and genes were annotated into 3 major ECM
categories: proteoglycans, glycoproteins, and collagens. CAGE peak data for each category
was gathered for all 511 samples in a matrix. All analysis was executed using Python version
3.6 [104] using multiple packages including pandas [105], NumPy [106], the sklearn.metrics,
sklearn.utils, in SciKits [107], Matplotlib [108], seaborn [109], and

scipy [110]. The

seaborn.clustermap function of the seaborn package was used to perform hierarchical
clustering of the heatmaps for each gene category using the average linkage representing the
Unweighted Pair Group Method with Arithmetic Mean (UPGMA) method and the Euclidean
distance metric to calculate the distance between each new cluster and the remaining cluster.
The ClusterMaps were annotated with color bars indicating the core tissue systems of the
samples. To demonstrate if the differences of CAGE expression across ECM-encoding genes
and the differences across samples were statistically significant, we converted the expression
values to z-scores. This was done by applying z-score transformation to the log2 transformed
data using the z-score statistical function from the stats module of the scipy package in
Python. To investigate the co-expression patterns of genes in each ECM category and
determine complex relationships in promoter activity, correlation analyses were conducted.
For these analyses, the log transformed data was used and the Pearson correlations were
calculated by evaluating pairwise correlations of all gene pairs after excluding all null values.
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5. Supplementary Materials

Supplementary Figure 2.1 Z-scores of proteoglycans across genes.
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Supplementary Figure 2.2 Z-scores of proteoglycans across samples.
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Supplementary Figure 2.3 Z-scores of glycoproteins across genes.
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Supplementary Figure 2.4 Z-scores of glycoproteins across samples.
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Supplementary Figure 2.5 Z-scores of collagens across genes.
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Supplementary Figure 2.6 Z-scores of collagens across samples.
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Supplementary Figure 2.7 Z-scores across extracted genes of the epithelial system
glycoproteins.
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Supplementary Figure 2.8 Extracted glycoproteins with negative correlation to LRG1.
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Supplementary Figure 2.9 Extracted region of glycoproteins with positive correlation to
LRG1.
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Supplementary Figure 2.10 Extracted region of interest from glycoproteins
correlation containing FGL2.
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CHAPTER 3 COLLAGEN XVII IN HUMAN SALIVARY GLANDS:
INFLUENCE ON DYNAMIC ASSEMBLY
1. Introduction
Radiation induced xerostomia, or dry mouth, is a major problem for patients
undergoing head and neck cancer treatment. In this process, radiation treatment in
the cranial region often damages the functional units of the salivary gland, leading to
long-term decrease in salivary flow [111]. Currently, there are no effective treatments
for xerostomia, meaning only palliative care can be provided [112]. It therefore
becomes essential to engineer new methods to combat dry mouth through the
promising avenue of tissue engineering. In this, we must better understand native
gland architectures and the effect of various proteins on salivary gland development
and homeostasis.

Temporal and special regulation of the ECM in the developing salivary gland is
essential to the development of complex tissue architecture [15]. It has been shown
that proteins of the collagen family regulate the process of branching morphogenesis
in human SMG [24] while proteins such as fibronectin more specifically regulate cleft
formation in the developing bud [16]. Interestingly, levels of proteins that mediate cellcell adhesions in these regions, such as E-cadherin, are strictly regulated, being
decreased by fibronectin expression at the cleft [113]. Laminins are expressed in high
amounts in the early stages of gland development but decrease over time and become
specifically localized to the duct as the intact basement membrane is formed and cellcell and cell-matrix adhesions mature [114].
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Type 1 hemidesmosomes are large anchoring complexes of the epithelium comprised
of integrin α6β4, plectin isoform 1a, laminin 332, CD151, bullous pemphigoid antigen
1 isoform e (BP230), and bullous pemphigoid antigen 2 (BP180, or collagen XVII) [39].
These anchoring complexes tie epithelium to the basement membrane through
transmembrane components such as collagen XVII and the α6β4 integrin pair. Type I
hemidesmosomes are compromised in diseases such as junctional epidermolysis
bullosa [115] and Sjögrens disease [116], manifesting in a wide range of clinical dental
complications, including lack of salivary flow from resulting glandular destruction.

Advances in large data analytics have made it possible to better understand and
appreciate how ECM proteins are expressed in their concerted order. The matrisome,
described in chapter 2, is one of the most comprehensive proteomics analyses on
ECM protein expression. In this analysis, a group of core and matrix-associated
proteins was defined based on their structural elements, with a resulting list of 274
core matrisome genes [49,117]. The Riken FANTOM5 SSTAR offers an opportunity
to further investigate the ECM in human samples using CAGE peak data to generate
a tags per million read that can be translated to represent quantitative measures of
gene promoter activity [98].

In this chapter, human salivary stem progenitor cells (hS/PCs) derived from human
salivary glands were analyzed for the highest promoter activity of core matrisome
ECM proteins using the FANTOM5 CAGE peak database. From this, an essential role
for collagen XVII was uncovered in salivary ductal progenitor cell migration and

38

homeostasis. To investigate this further, we used immunofluorescence to identify the
localization of collagen XVII in both human parotid gland (hPG) and human
submandibular gland (hSMG). From this, we found collagen XVII to be localized
specifically in the ducts of whole human tissue, adjacent to the basement membrane,
implicating its essential role in ductal homeostasis. We utilized both two- and threedimensional systems to assay the behavior of collagen XVII high (pre-ductal) and
collagen XVII low (pre-acinar) cell populations derived from the hPG as they assemble
into salivary microstructures. From these studies, we identified a potential role for
collagen XVII as a pre-ductal marker for hS/PC cell differentiation and a key
component of ductal formation. With this knowledge, we can implement better tissue
engineering approaches that focus on collagen XVII and type I hemidesmosome
formation to engineer biomimetic patient-derived salivary replacements for patients
experiencing radiation-induced xerostomia.

2. Results
2.1 COL17A1 is one of the most actively transcribed genes in hS/PCs and
localized almost exclusively to ducts
The core matrisome genes were combined with CAGE peak data from the FANTOM5
SSTAR. The dataset was further processed to extract hS/PCs. (Figure 3.1B) In an
analysis of the ECM in hS/PCs, the COL17A1 promoter was identified as one of the
most active in the top 10 most actively transcribed genes shown. (Figure 3.1A) In
immunofluorescence staining of tissue of the salivary gland (Figure 3.1C), ECM
laminin 111 was localized primarily to the acinar regions, while collagen IV and
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Figure 3.1 COL17A1 is one of the most actively transcribed ECM genes in hS/PCs and
is localized to the ducts. Top ten genes most actively transcribed in salivary hS/PC
samples pulled from the FANTOM 5 database. COL17A1 position highlighted by
magenta boxes in all three donor samples (A). Workflows showing the extraction of
salivary samples from the FANTOM 5 database (B). Immunofluorescence staining of
human parotid gland (hPG) and human submandibular gland (hSMG) for in various
patient samples (male 50 (M59) and male 77 (M77)) demonstrating localization of various
ECM proteins and salivary structures (C).
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collagen XVII were localized to the ducts of similar hPG and hSMG tissues.
Cytokeratin 19 (K19) and aquaporin 5 (AQP5) were used to mark the ductal and acinar
regions of the tissue, respectively.

2.2 Collagen XVII was differentially expressed in hS/PCs from different patients

Immunofluorescence of collagen XVII into hPG-derived hS/PCs showed differential
expression levels between patients. (Figure 3.2A) Male 50 (M50) hS/PCs expressed
the most collagen XVII as compared to male 33 (M33) and male 76 (M76) cells.
Additionally, M33 and M76 cells displayed differing morphologies on glass coverslips.
Western blot analysis of hPG hS/PCs showed varying levels expression of collagen
XVII across patients and passages. (Figure 3.2B & C) Across all patients, M50s
expressed the highest amount of collagen XVII as compared to female 50 (F50), male
68 (M68), and female 38 (F38). Some effect was observed among passages from
patient-derived cells such as F38s, but no consistent observation was made.

2.3 Knockdown of collagen XVII impacts the ability of hS/PCs to migrate in
2D
Scratch assays were used as a measure of cell motility dependent on collagen XVII
interactions with the substratum. A collagen XVII high (M50) and low (F38) hS/PC
population were assayed to determine the role of collagen XVII in migration.
Representative images of M50 cells are shown. (Figure 3.3A) Orange lines indicate
the migration front of the cell population after the scratch. At 12 hours, wild-type and
scramble cells showed similar amounts of migration, filling in the scratch, while cells
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Figure 3.2 Collagen XVII shows differential expression in patients with differing
morphologies. Immunofluorescence of collagen XVII (red) in hS/PCs on coverslips with
nuclei (blue) (A). Western blot of collagen XVII in various hS/PCs across different
passages (P) indicated on the graphic (B) with quantification of expression levels (C).
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Figure 3.3 Collagen XVII expression influences hS/PC migration. Representative images
of male 50 (M50) hS/PCs in wild-type (WT), siScramble, and siCOL17A1 treatment groups
at 0, 12, and 24 hours. Orange lines indicate the migratory front (A). Quantified scratch
assay area of M50 (orange) and female 38 (F38) (magenta) cells of various treatments at
0 and 24 hrs (B).
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with knockdown of collagen XVII demonstrated a delayed migration. After 24 hours,
wild-type and scrambled siRNA-treated cells continued to behave in a similar manner,
while collagen XVII knockdown prevented the ability of cells to migrate. Interestingly,
when quantified, F38 cells showed a different effect from this knockdown. (Figure
3.3B) In F38 cells, knockdown of collagen XVII enhanced the ability of cells to migrate
as opposed to the M50 (collagen XVII high) cells.

2.4 Collagen XVII expression is localized to the basement membrane side of
hS/PC microstructures
Salivary hS/PCs encapsulated in hyaluronic acid-polyethylene glycol diacrylate (HAPEGDA) hydrogels expressed collagen XVII adjacent to the basement membrane of
microstructures, regardless of patient origin. (Figure 3.4) Across time, these
microstructures grew in size, with a larger number of nuclei present in each structure
at week 2 and fewer single cells expressing K19. F-actin localization was concentrated
at cell-cell contacts in assembling microstructures while collagen XVII remained at the
periphery of whole microstructures. Cells did not readily migrate through this matrix,
but instead stayed as intact spheres.

2.5 Assembling hS/PCs with high collagen XVII expression mimic ductal
structure formation 3D culture
To assess the complex migratory behaviors of hS/PCs in three-dimensional space, a
migration-permissive, MMP-labile hydrogel system was used. This system consists of
an HA backbone with a pendant RGD integrin-binding motif and a PQ MMP-labile
crosslinker. The hydrogels are described as a ratio of thiol:acrylate and a ratio of 6:1
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Figure 3.4 Collagen XVII is localized to the basement membrane of hS/PC microstructures.
Immunofluorescence of collagen XVII (red), F-actin (white), K19 (green), and nuclei (blue)
in hS/PC microstructures in HA-PEGDA hydrogels at week 1 and 2.
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was determined as the best formulation for these cells. Once again, a collagen XVII
high (M50) and low (F38) hS/PC line were utilized in this experiment to test the
influence of collagen XVII on hS/PC microstructure formation and branching behavior.
After four weeks of culture, collagen XVII high M50s created dynamic, branched
structures that mimic those structures seen in developing salivary glands. These
structures were collagen XVII high on the distal ends and resembled maturing ducts.
(Figure 3.5A) The collagen XVII low F38 cells however, did not create branched
structures, and retained a spherical microstructure formation that resembled that of
an acinus. (Figure 3.5B) With this, we propose a working model that describes
collagen XVII as an essential ductal component for mature duct formation as opposed
to those mature acinar structures as illustrated in Figure 3.5C.

3. Discussion
The regulated dynamics of the ECM and cell-cell versus cell-matrix adhesions in the
developing salivary gland inform tissue organization and remodeling [33]. Type I
hemidesmosomes and cell-cell adhesions also play an essential role in the formation
of clefts and resulting buds seen in developing tissues [40]. In a comprehensive review
of the core ECM molecules found in salivary hS/PCs, we reveal a major insight into
the ECM molecules that may be essential to the generation of complex organization
of salivary structures, to be leveraged in tissue engineering approaches. In this work,
we found collagen XVII to be one of the most actively transcribed ECM genes in
hS/PCs. Upon further analysis, we revealed the unique localization of collagen XVII in
the primary ductal structures of intact hPG and hSMG. Collagen XVII is known for its
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Figure 3.5 Migration permissive PQ-RGD hydrogels allow for hS/PC re-organization in
collagen XVII high (pre-ductal) cells. Immunofluorescence of collagen XVII (red), F-actin
(white), and nuclei (blue) of M50 (A) and F38 (B) hS/PCs in PQ-RGD hydrogels at four
weeks. Diagram of salivary gland structures with a magnified acinar region leading to a
duct (C).
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role, when mutated, in the manifestation of epidermolysis bullosa or butterfly skin
disease, where epithelial anchoring complexes are lost and sloughing off of the skin
occurs. While this condition has been extensively studied, few reports exist of the full
implications in terms of overall salivary function and form. Some case reports
regarding the oral cavity of patients with this disease show severe dental caries and
loss of protective enamel, though whether or not salivary flow specifically contributes
to this is not known [115]. Similar loss of enamel is also seen in those patients with
Sjögrens syndrome, a disease defined by an overall loss of salivary flow and resulting
dry mouth [118]. Taken together, these results indicate a role for collagen XVII in
maintaining enamel and overall oral health.

Interestingly, the components of laminin 332 were also observed in the top ten actively
transcribed ECM gene promoters from the FANTOM5 samples. Laminin 332 is
another essential component of type I hemidesmosomes, implicating further the
essentiality of these cell-anchoring complexes salivary homeostasis. In patients with
Sjögrens, there has been an observed decrease in laminin 111 expression [19], and
disorganization in the α6β4 integrin pair that seems to disrupt hemidesmosome
formation in the acinar regions of diseased glands [116]. Interestingly, in a laminin
chain labeling study, laminin 332 was found in both acinar and ductal compartments
of the salivary gland though laminin 111 was localized specifically to acinar regions
[119], indicating the potential for these type I hemidesmosomes to be structurespecific.
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It is interesting to note that hS/PCs derived from different patients display varying
amounts of the collagen XVII protein, consistent with their differences in morphology.
We see in those cells with high collagen XVII levels, a distinct cobblestone phenotype
with tight cellular interactions, highlighted by their collagen XVII expression patterns.
Those cells that are low in collagen XVII have trouble sticking to the coverslips and
display a much more diffuse organization and more rounded cell shape than their
collagen XVII counterparts. Also interestingly, the amount of collagen XVII expression
seems to vary across passages in these hS/PCs, leading us to believe that earlier
passages of hS/PCs are essential to study this protein. In western blots of cell-cell
adhesions proteins such as E-cadherin (data not shown), we observe a trend in
expression of collagen XVII and E-cadherin expression, where hS/PCs with high
levels of collagen XVII often have corresponding high levels of E-cadherin, that we
believe warrants further investigation.

Scratch assays offer a simple method to interrogate the influence of various
treatments on the ability of cells to migrate on a substratum. In a scratch assay of
collagen XVII high versus low cells, we observed an interesting effect on hS/PCs,
dependent on their collagen XVII expression levels. In those cells that are collagen
XVII high (M50), the knockdown of collagen XVII greatly slows the population of cells
as they heal the scratch “wound”, however, in collagen XVII low cells, collagen XVII
knockdown seem to heal the “wound” faster, indicating their lack of reliance on
collagen XVII to migrate and interact with their substratum. Studies of pancreatic
ductal cell carcinoma provides some insight into the role of collagen XVII in ductal cell
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migration, where perturbation of collagen XVII impacts the ability of these cells to
migrate [120]. In a similar fashion, collagen XVII high cells exhibit a more ductal
phenotype where knockdown slows cell migration.

We have previously shown in cultures of hS/PCs that the assembly of microstructures
in HA-PEGDA is a dynamic process through which the cells express various ECM
proteins and exhibit a β1-integrin-mediated spinning and popping organizational
pattern [121]. In assembling microstructures here, we observe similar organizations
of cells, with intact cellular contacts, resulting in smooth, spherical structures.
Expression of collagen XVII in these structures localizes to the external surface, the
site of basement membrane assembly, presumably allowing these cells to interact
with and anchor to their synthesized basement membranes. This anchoring could be
indicative of cellular adhesions precluding polarization and resulting differentiation.
We know from previous work, that these specific ECM protein type interactions
influence the ability of these cells to form complex, differentiated structures that most
closely represent the architecture of native tissues [21]. We also know that HAPEGDA hydrogels don’t allow for complex organization of these hS/PC
microstructures, and therefore meant a more complex, modifiable culture system was
needed to observe the difference in collagen XVII high versus low cell behaviors [122].

PQ-RGD migration-permissive hydrogels have been shown to allow for complex
cellular assembly of hS/PC microstructures and to encourage the expression of more
differentiated ECM [122]. We used this same system here to allow collagen XVII high
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versus low hS/PCs to develop into more complex architectures that better mimic their
desire to go down a specific cell lineage. In these cultures, the collagen XVII high cells
organized into more branched, ductal-like structures, with long protrusions coming
from the original cell cluster, similar to what is seen in developing salivary glands. In
collagen XVII low cells however, this organization was not observed and cells retained
a more rounded and smooth surface, similarly to what has been seen in more acinarlike cell cultures. With this, we believe that collagen XVII may serve as a ductalspecific director of cell motility and may influence the potential of these stemprogenitor cells to distinguish between cell lineages. As our lab focuses on tissue
engineering applications for these cell systems, this knowledge could be crucial in
understanding how to develop more complex salivary microtissue for re-implantation
into patients recovering from radiation-induced xerostomia.

4. Materials and Methods
4.1 Tissue Processing & Cell Culture
Human salivary gland samples were provided courtesy of Stanford University and the
University of Delaware under institutional IRB approval for resection of an unaffected
normal portion of parotid or submandibular gland with patient consent. Deidentified,
resected human salivary tissue was shipped overnight on ice and arrived at UTHealth
School of Dentistry for processing. Processing of tissue includes portioning and
designation of fate to either optimal cutting temperature (OCT) embedding or
explanting. OCT embedded tissues were flash frozen and stored at -80°C for longterm storage until sectioning with a cryostat. Portions of the tissue designated for
51

explanting and derivation of human stem/progenitor cells (hS/PCs) were prepared as
previously described [22]. hS/PCs were cultured in William’s E medium (VWR 10128636) supplemented with 10 ng/mL human epidermal growth factor (Gibco PHG0311),
10 µM dexamethasone (Sigma Aldrich D4902-25MG), 1% (v/v) GlutaMax (Gibco
A1286001), 1% (v/v) insulin transferrin selenium (InVitria 777ITS091100ML), 1 mg/mL
(w/v) human serum albumin (Sigma Aldrich A188710G), and 1% (v/v) pencillinstreptomycin (Gibco 15140122). Cells were maintained at 37°C in humidified
atmosphere of air:CO2 95:5 (v/v) incubator as described previously [21]. Cells were
detached for passaging at 90% confluence using 0.125% (w/v) Trypsin 380 mg/L
EDTA (Gibco 25200072 + 50% (v/v) PBS). Trypsinization was stopped with a volume
of soybean trypsin inhibitor (Millipore Sigma T6522) equal to that of the trypsin and
centrifuged. Pelleted cells were split at 1:3 ratio to a new T-75 flask in complete
William’s E medium.

4.2 Immunocytochemistry
Samples were gently washed with 1x phosphate buffered saline (PBS) without calcium
and magnesium then transferred to 4% (w/v) paraformaldehyde for 10 minutes at
room temperature (RT) then washed 3 times with 1x PBS. Samples were
permeabilized in 0.2% (v/v) Triton X-100 (Thermo Scientific A16046AP) for 4 x 5
minutes with agitation. Samples were blocked with 10% (v/v) goat serum pH 7.4
diluted in 0.2% (v/v) Triton X-100 for 1 hour at room temperature with agitation.
Samples were incubated with primary antibodies diluted at 1:100 in 10% (v/v) goat
serum overnight at 4°C. Primary antibodies used in this study were collagen XVII
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(Abcam ab184996), K19 (Abcam ab7754), K5 (BioLegend 905501), laminin 111
(Novus Biologicals NB300-144), AQP5 (Abcam ab92320), and collagen IV (Novus
Biologicals NBP1-97716).

4.3 siRNA & Scratch Assays
Salivary hS/PCs were seeded at a cell density of 200,000 cells (M50) or 400,00 cells (F38)
per well in a 24-well dish. After 48 hours of recovery in complete media, cells were treated
with siRNAs (ThermoFisher Scientific Silencer Select Negative Control No. 1 siRNA 4390843
(siScramble) and siRNA ID s3359 (siCOL17A1)) using a general Lipofectamine RNAiMax
protocol. Briefly, a mixture of 100 µL of Opti-MEM reduced serum media (Gibco 31985062)
was mixed in a 1.5 mL Eppendorf tube with 6 µL Lipfectamine RNAiMax. In a second 1.5 mL
centrifuge tube, 100 µL of Opti-MEM was mixed with 2 µL of 10 µM siRNA guides (siScramble
or siCOL17A1). The contents of both 1.5 mL centrifuge were then combined and allowed to
incubate for 5 minutes at room temperature. After 5 minutes, the Lipofectamine-siRNA guide
complexes were added to the respective cell well and an additional 400 µL of Opti-MEM was
added to each well, for a final volume of 500 µL per well. Lipofectamine-siRNA guide
complexes were allowed to incubate on cells for 6 hours in a 37֯C incubator. After 6 hours, the
Opti-MEM complex mixture was removed and complete media was added back to the cells.
A second dose of siRNA treatment was repeated after 24 hours and the cells were allowed to
recover overnight. The next day, cell layers were scratched with the end of a 200 µL pipette
tip and washed briefly with PBS to remove detached cells and cell debris. Complete salivary
cell media then was added back to the well and the cell plate was transferred to the BZ-X810
Keyence with a connected Tokai-Hit Thermal Plate for temperature and CO2 control. Using
the stitch feature on the Keyence, areas were assigned in a 3 x 3 grid across the entirety of
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the scratch area and cells were imaged at 4x every hour for 24 hours. Stitched images were
retrieved from the Keyence and processed using ImageJ MiToBo plugin [123].

4.4 Encapsulation and Hydrogel Culture
Media was removed and 3.6 million cells were resuspended in 1 mL of 10 mg/mL
Glycosil (HA) (ESI BIO GS222) that had been resuspended in degassed water per the
manfacturer’s instructions. For HA-PEGDA hydrogels, cell resuspension in HA was
followed addition of 250 µL ExtraLink (PEGDA) resuspended in 500 µL degassed
water per the manufacturer’s instructions. The material was allowed to crosslink for 5
minutes then cast into 50 µL cylinders in PDMS molds at a typical dimension of 6 mm
in diameter and 2 mm in height and allowed to crosslink in the incubator. After 1 hour,
hydrogels were removed from the PDMS molds and cultured in 1 mL of media in a 24well culture plate.

Encapsulation with PQ-RGD hydrogels utilized peptides

KGGGPQG↓IWGQGK (PQ peptide (down arrow indicates the cleavable bonding site))
and GRGDS (RGD peptide) that were purchased from Genescript USA inc. and
reacted as previously described [124,125]. Briefly, RGD at 73.7 mg/mL was added to
the Glycosil cluster suspension and then mixed into solution with a pipette with a cut
off end. The combined Glycosil-RGD mixture was adjusted to pH 7.8 with 1M NaOH.
PQ at 22.49 mg/mL was added and then mixed as previously described [122,124,126].
The solution was allowed to begin crosslinking for 10 min prior to casting in PDMS
molds, similar to HA-PEGDA.
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CHAPTER 4 THE PSPN COMPLEX AS A MOLECULAR SWITCH IN
PROSTATE CANCER METASTASIS
This chapter was modified from Tellman, T.V., Cruz, L.A., Grindel, B.J., and Farach-Carson,
M.C. Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by
Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Dyscohesion and Migration.
Int J Mol Sci. 2021 Mar; 22(6): 3218. doi: 10.3390/ijms22063218 and portions of Grindel, B.J.,
Martinez, J.R., Tellman, T.V., Harrington, D.A., Zafar, H., Nakhleh, L., Chung, L.W., and
Farach-Carson M.C. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with
Semaphorin 3A Supports FAK-Mediate Stromal Invasion by Prostate Cancer Cells. Sci Rep
8, 7262. May 2018. doi: 10.1038/s41598-018-25435-3. Int J Mol Sci and Sci Rep articles are
published under a CC BY 4.0 license under which authors retain copyright permissions for
their articles.

1. Introduction
Among the non-collagenous components of the ECM, the large heparan sulfate proteoglycan
perlecan/heparan sulfate proteoglycan 2 (HSPG2) plays a unique role in coordination of
signaling complexes on the surfaces of the cells that it engages. As we previously proposed
[127], perlecan can be considered as an extracellular scaffolding protein in which each of its
five structural domains interacts with various classes of surface complexes including growth
factor receptors (domain I), low-density lipoproteins (domain II), calcium channels (domain
III), cell–cell adhesion molecules (domain IV), and cell–substratum interactions (domain V)
[128,129]. Our laboratory has spent many years exploring the detailed functions of domain IV
in the human protein, which consists of 21 Ig-like modules in three functional subdomains (1–
3) with two basic structural motif types [129]. Clustering behavior by the last 7 Ig-repeats in
domain IV (Dm IV-3) has been observed in both cancer [130] and normal [131,132] cells.

55

Previous work also showed that full-length, fully decorated perlecan (FL pln) induces
clustering of PCa cells when pre-coated onto surfaces [130,133].

Perlecan, when fully decorated with its three to four GAG chains, consisting of a cell typedependent ratio of heparan and chondroitin sulfate chains [134], is highly resistant to
proteolysis by most extracellular proteases [135]. Removal of the GAG chains by
endoglycosidases renders the core protein more susceptible to digestion [135]. MMP-7
possesses the ability to extensively digest the perlecan core protein while still fully decorated
with GAG [130]. Digestion with MMP-7 releases the perlecan scaffolding function and alters
intracellular signaling, a phenomenon we have referred to as a “molecular switch” for
dyscohesion [130,133,136]. Cleavage of perlecan by MMP-7 occurs from the C-terminal,
releasing protein fragments of various sizes primarily from domains IV and V [130]. These
fragments were mapped by mass spectrometry and shown to be present in the sera of patients
with metastatic cancer [137]. Among these, one domain IV-derived MMP-7-produced
fragment contains a 17 amino acid peptide sequence, perlecan 4 (PLN4) peptide, that we had
previously identified to have a unique activity in cell–substratum adhesion and activation of
focal adhesion kinase (FAK) [138]. Cadherins are primary mediators of cell–cell adhesion. Ecadherin performs this dynamic function in epithelial cells particularly for homotypic
interactions among like-type cells [139]. Stabilization of E-cadherin-mediated binding is
supported by cortical actin that “locks” cell–cell adhesion. Thus, co-localization of E-cadherin
and the actin cytoskeleton can serve as an index of tight cell cohesion [140]. MMP-7 also can
cleave E-cadherin, leading to shedding of the ectodomain and cell dyscohesion [141,142].

In this work, we identified the perlecan-stabilized perlecan-semaphorin 3A-plexin A1neuropilin-1 (PSPN) complex and assessed the ability of MMP-7 to digest all components in
the context of PCa, a metastatic disease with a proclivity to metastasize to the perlecan-rich
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bone marrow where it further metastasizes by production of circulating tumor cells (CTCs)
[129,143,144]. Using a preformed microtumor model developed for this project, we also
examined the initiation of cell migration after MMP-7 digestion and tested the hypothesis that
the bioactive PLN4 peptide produced by MMP-7 digestion of perlecan could further enhance
cell migration. Finally, we investigated the ability of digestion with MMP-7 to destabilize cell–
cell junctions in microtumors using co-registration of E-cadherin, F-actin, and β-catenin as a
quantitative tool to study the quality of cell adhesion complexes.

2. Results
2.1. Knockdown of semaphorin 3A and plexin A1 prevents clustering on Dm
IV-3
Wild-type C4-2 cells plated on Dm IV-3 demonstrated a clustering cell behavior [145].
Knockdown of secreted semaphorin 3A (SEMA3A) via shRNA prevented the clustering of C42 PCa cells on Dm IV-3 coated wells (Figure 4.1A) as opposed to controls (Figure 4.1B).
Knockdown of plexin A1 showed a similar inability to cluster of Dm IV-3 coated wells (Figure
4.1C) as opposed to shRNA control (Figure 4.1D). Taken together, these results indicated a
role for SEMA3A and plexin A1 in the ability of PCa cells to cluster on Dm IV-3-treated wells.

2.2. PSPN complex components co-distribute on the cell surface when
stabilized by Dm IV-3
The PSPN complex forms as a dimer of heterotrimers stabilized by extracellular perlecan
(Figure 4.2A). Extracellular perlecan/HSPG2 interacts with secreted SEMA3A to bind NRP1
(dotted arrow) and plexin A1 to stabilize the PSPN complex and prevent PCa dyscohesion.
Dm IV-3 stabilized PSPN complex components interact at the a1 domain of NRP1 (light blue
square), which acts as a bridge between the sema domains (blue and dark green) of SEMA3A
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Figure 4.1 Knockdown of SEMA3A and plexin A1 prevents clustering of C4-2 PCa cells on
Dm IV-3. Control (A & C) cells cluster on Dm IV-3 treated wells. Knockdown of SEMA3A
(B) and plexin A1 (D) by siRNA prevents cluster formation on Dm IV-3 coated wells. Scale
bar = 250 µm
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Figure 4.2 The PSPN Complex is stabilized at the cell surface by Dm IV-3 on PCa cells. Dm
IV-3 of perlecan (light green oval) interacts with the Ig module (light green) in the SEMA3A
dimer. Subsequently, this stabilized dimer interacts with NRP1, which acts as a bridge
between SEMA3A and plexin A1. The sema domains of both SEMA3A (blue) and plexin A1
(dark green) interact at NRP1 as a dimer of heterotrimers (A). Representative image of
proximity ligation assays spots (green) between NRP1 and SEMA3A (B). Scale bar = 100
µm.
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and plexin A1. The entire complex assembles as a dimer of heterotrimers stabilized at the cell
surface. Proximity ligation assays of Dm IV-3 clustered cells showed a number of colocalization events (green spots) between NRP1 and SEMA3A (Figure 4.2B).

2.3. In Silico digestions of plexin A1 and neuropilin-1 by MMP-7
In silico digestion of FL pln [130] and SEMA3A [133] was reported previously. SitePrediction
online software was used to analyze the ability of MMP-7 to cleave cell-surface plexin A1 and
neuropilin-1 (NRP1) in silico. Schematics of plexin A1 and NRP1 (Figure 4.3A & B) show the
top ten predicted MMP-7 cleavage sites, all with specificity >99%. Predicted cleavage sites
are indicated on the schematic with the cleavage sequence and accompanying rank order,
with 1 representing the most likely cleavage. The most likely cleavage site in plexin A1
produced a 137.5 kilodalton (kDa) N-terminal fragment that contained the interacting sema
domain (Figure 4.3A). The most likely NRP1 cleavage site in the VEGF b1 domain produced
a 64.8 kDa N-terminal fragment containing the SEMA3A-plexin A1-binding a1 domain (Figure
4.3B). Predicted ribbon structures were created in silico to demonstrate the availability of
predicted cleavage sites within the context of three-dimensional space. Cleavage sites are
indicated by color-coded keys (Figure 4.3C & D). PHYRE modeling could not accurately
predict all regions of the plexin A1 and NRP1 structures because of a lack of available
homology, so not all cleavage sites could be represented. In silico predictions thus
demonstrated the likelihood that MMP-7 could cleave both NRP1 and plexin A1 at multiple
cleavage sites (Figure 4.3).
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Figure 4.3 In silico predictions demonstrate MMP-7's potential to cleave plexin A1 and
NRP1. In silico digestion of (A) plexin A1 and (B) NRP1 using MMP-7 cleavage sequence
information in SitePrediction online software. Schematics of plexin A1 and NRP1 are
shown with representative domains and relative location of the top ten predicted cleavage
sites. Numbers represent the ranked score for each sequence with the corresponding
amino acid sequence, with exact cleavage indicated by the period. PHYRE models of
plexin A1 (C) and NRP1 (D) show the predicted ribbon structures with corresponding
cleavage sites denoted by color.
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2.4. Demonstration of digestion of all PSPN complex components by MMP-7
Previous work from our lab demonstrated the ability of MMP-7 to cleave FL pln with intact
GAG [130]. Dm IV-3 was cleaved into limit peptides with proposed bioactivity [130,138].
Purified Dm IV-3 was digested with MMP-7 into these limit peptides, consistent with FL pln
digestions, with five major bands containing these fragments [130]. The resulting Dm IV-3
fragments ranged from 17 to 53 kDa. Recombinant SEMA3A, a secreted member of the PSPN
Complex, was digested with MMP-7 to assay for cleavage sequences within the protein then
electrophoresed using SDS-PAGE and visualized by silver staining. Digestions yielded
multiple bands, the most prominent of which was approximately 30 kDa [133]. A recombinant
portion of plexin A1 ectodomain was incubated overnight with MMP-7 to validate in silico
predictions. The resulting silver stain showed extensive proteolysis, producing a single major
band at 15 kDa, indicative of multiple cleavages within the predicted regions (Figure 4.4C).
Following in silico predictions, recombinant NRP1 was digested overnight with MMP-7 to
determine experimentally the ability of MMP-7 to cleave NRP1 at the predicted cleavage
sequences. A silver stain of the digestion showed nearly complete digestion of the protein,
with two major bands detected at 20 and 15 kDa (Figure 4.4D). Taken together, these results
indicated that MMP-7 plays a major role in the cleavage and resulting destabilization of the
PSPN Complex.

2.6. Cells on intact Dm IV-3 demonstrated differential distribution than those
in 2D
C4-2 PCa cells plated on Dm IV-3 displayed plexin A1 on the surface of the cluster, stabilized
by intact Dm IV-3 (Figure 4.5A) . F-actin remained localized to cell-cell contacts in intact
clusters (Figure 4.5A). Cells in 2D (no Dm IV-3) showed diffuse distribution of plexin A1
localized adjacent to the nucleus in the cytoplasm (Figure 4.5B). F-actin in cells without Dm
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Figure 4.4 In vitro digestions of all PSPN Complex components demonstrate susceptibility to
proteolysis by MMP-7. Silver staining of Dm IV-3 incubated with or without MMP-7 (adapted from
[130]) (A), MMP-7 digestion of SEMA3A-Fc (0.75 µg) with or without MMP-7 (0.08 µg) overnight
(adapted from [133]) (B). Digestion of recombinant plexin A1 (2 µg) (C) and NRP1 (2 µg) (D)
overnight with or without MMP-7 (0.2 µg). Black arrows indicate recombinant Dm IV-3, SEMA3A-Fc,
plexin A1, NRP1 and MMP-7.
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Figure 4.5 C4-2 PCa cells treated with Dm IV-3 show surface distribution of PSPN Complex
components as compared to non-treated controls. Plexin A1 (red) is localized to the surface of the
intact PCa cell cluster on Dm IV-3 and F-actin (white) localization remains at contacts (A). In nontreated controls (PBS only) cells display diffuse plexin A1 and F-actin localization.
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IV-3 was diffuse and distributed throughout the cell. Additionally, cells in 2D had long
projections, indicating cell-substratum interactions that were not present in Dm IV-3 treated
cells.

2.5. MMP-7 promotes and perlecan inhibits cell dispersion
To determine whether preformed PCa microtumors will retain their clustered, cohesive
phenotype when exposed to soluble perlecan, MMP-7, or PLN4 peptide [138], the microtumor
formation assay was developed (Figure 4.6). A 24-well plate microwell system was used to
form similarly sized microtumors (Figure 4.6A″ & A‴). C4-2 PCa cells were chosen among
several PCa cell lines we tested (Supplementary Table 4.1), because they responded to
perlecan by clustering and did not produce detectable levels of endogenous MMP-7 that
prevents clustering. C4-2 cells were seeded at a density of 100,000 cells per well and
incubated for 24 hours (Figure 4.6A′). On day 2, microtumors were transferred to FL pln (pretreatment) and incubated for 24 hours (Figure 4.6B). On day 3, microtumors were transferred
to 96-well plates and a treatment was added to the cell culture media—bovine serum albumin
(BSA), FL pln, MMP-7, PLN4 peptide, or PLN4 peptide + MMP-7—and the behavior of cells
was followed by continuous live-cell imaging (Figure 4.6C). On day 4, a second, identical
treatment was performed (Figure 4.6C). On day 5, live-cell imaging was stopped, and images
were analyzed (Figure 4.6D).
Figure 4.7 shows the results of these experiments, examined for differences in treatment and
time. The spreading area of microtumors treated with FL pln was half that of those treated
with MMP-7 at all time points (Figure 4.7B). Note that the mean fold change area values inside
the red squares (Figure 4.7C) at 48 hours for FL pln was similar to the fold change value of
MMP-7 and MMP-7 + PLN4 peptide values at 24:30. This suggests that microtumors
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Figure 4.6 Microtumor formation assay. To evaluate the impact of FL pln, MMP-7 and PLN4
peptides on microtumor dispersion, uniformly sized C4-2 microtumors were pre-formed
using a 24-well plate microwell system (Kugelmeiers AG. Zürich, Switzerland) (A). One
single well of a 24-well plate contains 750 microwells that allowed us to form 750
microtumors of approximately 133 cells per microtumor (A′), (A″). These pre-formed
microtumors were transferred to FL pln or Dm IV-3-coated wells for ~24 h (B). Next,
microtumors were transferred again to uncoated wells or collagen I-coated wells, and the
indicated consecutive treatments in (C) (blue text) were added to the cell culture media.
Live-cell imaging (D) stopped at ~48 h and cell dispersion area was quantified (see Figure
5). Scale bars: 100 µm.
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Figure 4.7 Time course analysis of microtumor dispersion under control conditions
(no treatment, BSA) or in the presence of FL pln, MMP-7, and/or PLN4 peptide. (A)
Representative micrographs showing cell dispersion of C4-2 microtumors with the
indicated treatments and time points (scale bar: 100 µm). Yellow dotted lines on the
micrographs show the region of interest corresponding to total microtumor dispersion
area used to compute area fold change. (B) Evaluation of area fold change. Cell
dispersion area is higher in microtumors treated with MMP-7 or MMP-7 in combination
with PLN4 peptide compared to microtumors treated with FL pln (see text). Data are
the mean ±SEM of three experimental repetitions, except two experimental repetitions
for PLN 4 + MMP-7. * p < 0.05, ** p < 0.01. Two-way repeated-measures ANOVA with a
post hoc Šídák test was performed. (C) Table shows mean values for fold change in
area. Red wireframes demonstrate that the difference in time needed to reach a similar
amount of dispersion in the different treatment conditions.
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continuously treated with FL pln display a suppression in cell dispersion area and that
persisted at all time points (Figure 4.7C & Supplementary Table 4.2) Microtumors treated with
MMP-7 rapidly dispersed to create large, irregular structures with exposed regions of the plate
(Figure 4.7A). PLN4 peptide alone did not have a significant effect on the cell dispersion area
(Figure 4.7B), but clusters treated with the PLN4 peptide + MMP-7 tended to disperse farther
and more irregularly than those with MMP-7 alone. (Figure 4.7A & B). In the PLN4 peptide +
MMP-7 treated cells, rapidly spreading cells leaving dyscohesive microtumors also left empty
spaces (Figure 4.7A). The difference in cell dispersion area became striking at the 36 hour
timepoint for MMP-7 and MMP-7 + PLN4 peptide-treated microtumors; we observed a ~6-fold
and ~7.6-fold increase in area, respectively (Figure 4.7B & C). Overall, a near-complete
dispersion was observed in all treatment groups except for microtumors treated with FL pln at
48 hours. These data show that MMP-7 can disperse microtumors pre-treated with FL pln,
while the continuous presence of FL pln impairs cell spreading and favors a cohesive
phenotype. The presence of MMP-7 + PLN4 peptide is the most dyscohesive treatment that
we tested (Figure 4.7C).

2.7. MMP-7 disrupts cadherin-based cohesion
To assess cell adhesion complexes during microtumor cohesion/dyscohesion, microtumors
were pre-treated with Dm IV-3 on day 2 (Figure 4.6B) and transferred to collagen I-coated
wells on day 3 (Figure 4.6C). E-cadherin and F-actin immunostaining were performed 24 hour
after treatment with Dm IV-3 and MMP-7 (Figure 4.8) and the extent of co-registration of signal
was used as an index of cell–cell adhesion. Fluorescence intensity profiles of E-cadherin and
F-actin at the zones of cell–cell interactions (black arrows on linescans) showed high signal
co-registration in Dm IV-3-treated microtumors at cell–cell contacts, while the co-aligned
intensity peaks in microtumors treated with MMP-7 were substantially fewer. These findings
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Figure 4.8 Immunostained microtumors for E-cadherin (red) and F-actin (green) at 24
hours. Line scan analyses (see text) were performed for the regions highlighted by the
white arrows. Arrow 1: microtumor center, arrow 2: microtumor periphery. Dm IV-3-treated
microtumors show increase in co-aligned E-cadherin (red line) and F-actin (green line) at
cell–cell contacts (black arrows) whereas microtumors treated with MMP-7 show a
decrease in E-cadherin and F-actin co-alignment, indicative of loss of adhesion and
initiation of cell dispersion. Line scans were performed on multiple cell–cell boundaries
in microtumors under a variety of cohesive and dispersing conditions, then Pearson’s
correlation analysis was performed on the same clusters at high magnification (3
clusters/condition). The images shown are representative of what we observed. Scale
bars: 30 µm.
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demonstrate that MMP-7 treatment of PCa cells results in rearrangement of E-cadherin and
F-actin at cell–cell contacts that can contribute to dyscohesion and cell dispersion from
microtumors. Interestingly, the microtumors treated with MMP-7 showed more invadopodia
than those left untreated. Microtumors treated with Dm IV-3 showed an increase in E-cadherin
and F-actin at cell–cell contact zones at the center and at the periphery. Thus, the likelihood
of PCa cells leaving microtumors treated with Dm IV-3 is decreased compared to those treated
with MMP-7.

2.8. E-cadherin and β-catenin colocalize at cell-cell junctions in Dm IV-3treated microtumors
Immunostaining of E-cadherin and β-catenin demonstrated a unique protein distribution
signature for each treatment group. Microtumors were clustered with Dm IV-3 then treated
with BSA (no treatment) (Figure 4.9A), Dm IV-3 (Figure 4.9B), MMP-7 (Figure 4.9C), and
MMP-7 + Dm IV-3 fragments (Figure 4.9D). Non-treated microtumors (NT) (Figure 4.9A) and
Dm IV-3 (Figure 4.9B) showed a unique pattern of E-cadherin and β-catenin distribution, with
overlapping E-cadherin and β-catenin expression. When treated with MMP-7 (Figure 4.9C),
cells began to disperse and co-registration of E-cadherin and β-catenin was lost. In cells
treated with MMP-7 + Dm IV-3 fragments (Figure 4.9D), a similar pattern was observed, with
a larger dispersion index observed. Proximity ligation assays between E-cadherin and βcatenin on treated microtumors showed a similar trend in co-localization of these proteins.
Proximity events (green spots) were decreased in MMP-7 (Figure 4.9G & G’) and MMP-7 +
Dm IV-3 fragments (Figure 4.9H & H’) treatments as compared with NT (Figure 4.9E & E’)
and Dm IV-3 (Figure 4.9F & F’) treated groups.
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Figure 4.9 Immunostained microtumors for E-cadherin (red) and β-catenin (green)
correlate with proximity ligation assays. Microtumors with no treatment (NT) (A), Dm IV-3
(B), MMP-7 (C), and MMP-7 + Dm IV-3 fragments (D). Representative proximity ligation
assay (PLA) NT (E), Dm IV-3 (F), MMP-7 (G), and MMP-7 + Dm IV-3 fragments (H) images
with PLA spots (green) and DAPI (blue). Scale bars: 100 µm.
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3. Discussion
The dynamic interaction between MMP-7 and perlecan in metastatic PCa cells is a key
regulator of cell behavior in the tumor microenvironment [130,137]. Chronic inflammation of
the tumor microenvironment surrounding PCa tumors increases perlecan production, creating
a perlecan-rich stromal matrix [146]. For PCa cells to metastasize, they must degrade the
perlecan-rich matrix and create space to move. To do this, they either need to produce a
combination of proteases able to degrade the core protein along with GAGases able to first
cleave away the GAG chains, or they can produce a metalloproteinase that is able to cleave
fully decorated perlecan such as MMP-7. Highly aggressive PCa cells produce significant
amounts of MMP-7 [137,147,148]. We showed previously that MMP-7 can cleave native
perlecan bound up in the extracellular matrix, allowing PCa dispersion and invasion through
the matrix [130].

Until recently, the mechanism of receptor activation by perlecan at the PCa cell surface
remained elusive. This changed with the identification of a new surface complex, dubbed the
PSPN complex, , described here, which exists as a dimer of heterotrimers stabilized by
perlecan via an interaction between Dm IV-3 and the Ig region of SEMA3A, forming a
homotypic Ig–Ig interaction, as shown in Figure 4.1. This dimerization is essential to the ability
of the complex to activate downstream signaling as shown by several groups [149,150]. Based
on crystal structures of the SEMA3A–NRP1–plexin A1 interaction at the sema domains, the
a1 region of NRP1 forms a stabilizing brace to facilitate interactions between SEMA3A and
plexin A1 at the fifth and sixth β-propeller blades of each their respective sema domains [151].
Previous work identified the interaction between Dm IV-3 and MMP-7, but no studies
investigated the impact of activated MMP-7 on other PSPN complex components. Initially, we
looked to predictive models to provide insight into PSPN complex dynamics and found
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numerous cleavage sites within both plexin A1 and NRP1. Subsequent in vitro digestions
demonstrated that MMP-7 proteolysis can destroy all components of the PSPN complex, an
event that we showed favors dyscohesion, dispersion and cell migration, events associated
with formation of CTCs and metastasis in PCa. Limit fragments resulting from the digestion of
Dm IV-3 by MMP-7 were analyzed previously by our group where we predicted these to have
bioactive roles to enhance PCa cell dispersion [130]. It is not unreasonable then to assume
that derivative protein fragments resulting from PSPN complex cleavage could perpetuate
PCa dispersion and metastasis given the role of the SPN portion of this complex identified in
cell migration. It is worth noting here that the region of NRP1 that forms the bridge between
SEMA3A and plexin A1 is a likely portion to be released by MMP-7 cleavage of the protein.
To investigate the impact of perlecan and MMP-7 during microtumor cell dispersion, we
developed the microtumor formation assay. The bone metastatic PCa C4-2 cells used in this
study are an androgen-insensitive cell line derived from LNCaP cells with little inherent MMP7 production in the absence of inflammatory cytokines (Supplementary Table 4.1), making
them an ideal candidate for this type of analysis in investigating MMP-7′s role in dispersion
[152,153]. We note that among other cell lines of different prostate cancer subtypes (PCS) we
examined, LNCaP cells (PCS2) behaved similarly to C4-2 in clustering assays and expressed
low amounts of MMP-7 whereas two other highly aggressive cell lines, LNCaP RANKL (PCS
not profiled) and PC3 (PCS3), both of which constitutively produce MMP-7, either failed to
cluster or formed small clusters (Supplementary Table 4.1) [154]. We have not systematically
measured dispersion, E-cadherin or F-actin rearrangements in the LNCaP line. In this paper,
we report our findings that FL pln decreased cell dispersion from the C4-2 microtumors,
whereas MMP-7 led to a complete cell dispersion phenotype. We also present a qualitive
determination of cell–cell adhesion states, where microtumors treated with Dm IV-3 present
more co-aligned E-cadherin, F-actin , and β-catenin at cell–cell contacts than do microtumors
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treated with MMP-7. Several reports showed that both E-cadherin and F-actin need to be
present at cell–cell contact zones to maintain close cohesion between cells [155–157]. As a
result, the decrease in E-cadherin, F-actin, and β-catenin at cell–cell contacts zones on
microtumors treated with MMP-7 can result in microtumor dyscohesion, such as would occur
when tumors release CTCs.

Prostate cancer is not a homogeneous disease. It was of interest that the levels of MMP-7
produced by the various PCa cell lines that we tested, representing different PCS, directly
correlated with their ability to cluster on pln. Both LNCaP and C4-2 cells are of a more indolent
PCS2 as recently profiled by comprehensive study of gene expression [158] and made little
or no MMP-7. In contrast, a highly metastatic, bone destructive subline of LNCaP expressing
RANKL and in which c-Myc is active [154] did not cluster suggesting these cells are already
dyscohesive. PC3 cells, representing another aggressive PCa subtype PCS 3 [158] fell
somewhere in the middle, displaying some clustering that fell short of that observed with the
LNCaP series lines. Previous work in our lab [133] determined that the AKT pathway lies
downstream of the PSPN complex (Figure 4.10) and is activated by MMP-7. Pathway analysis
of the Prostate Cancer Transcriptome Atlas (PCTA) [158] showed that the AKT pathway is
most important in cells and tumors with the PCS2 subtype (Supplemental Figure 4.1). We
confirmed by western blot with two commonly used prostate cancer cell lines of different
subtypes that active pAKT levels were higher in PCS2 line C4-2 than in PCS3 line PC3
(Supplemental Figure 4.1). We suggest that our findings reported here are most applicable to

PCa tumors with a luminal PCS2 subtype, and perhaps a more aggressive luminal PCS1
subtype, and less relevant for cancers that already produce significant amounts of MMP-7
that can readily cleave the PSPN complex components.
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Figure 4.10 Proposed model of the PSPN Complex and E-cadherin/F-actin interaction in
cohesive versus dyscohesive PCa clusters. Model of the dynamic interactions between
the PSPN Complex, MMP-7, and E-cadherin/F-actin. Perlecan and SEMA3A secreted by
the PCa surrounding stroma bind to and silence signaling from the plexin A1-NRP1
proteins. When unproteolyzed by MMP-7, this prevents activation of downstream FAK,
AKT, and FOXM1, preventing dyscohesion. At this point, E-cadherin homodimers are
intact and the cortical F-actin cytoskeleton is organized near the cell surface. Upon
activation of MMP-7, cleavage of the PSPN Complex and extracellular E-cadherin
ectodomain occurs, activating integrins, and releasing PCa cells to initiate dyscohesion
and migration. Colors and shapes of the PSPN Complex components are as described in
Figure 3.1.
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The release of pro-migratory bioactive fragments from some or all members of the proteolyzed
PSPN Complex could further increase dispersion of intact PCa cell clusters. PLN4 peptide did
not itself increase microtumor cell dispersion, but when combined with MMP-7, cell dispersion
area increased noticeably over MMP-7 alone. This suggests that for PLN4 peptide to increase
cell motility, the cell–cell adhesions must first be loosened by MMP-7. Future work will
determine whether other perlecan fragments or other components of the PSPN Complex
resulting from MMP-7 digestion have this same ability. The usefulness of the microtumor
formation assay reported here is that it allows us to combine quantitative migration analyses
and more detailed morphological and molecular analyses to fully determine the impact of
PLN4 peptide or other bioactive fragments generated by MMP-7. In the context of
understanding the mechanisms that underly MMP-7′s ability to facilitate metastasis of PCa, it
is useful to link the events occurring at the cell surface with intracellular signaling pathways
and gene expression. In previous analyses of differences in the phosphoproteomes in
perlecan-induced cohesive and MMP-7-treated dyscohesive cells, we found that the PSPN
complex signaled to downstream FAK and FOXM1 [133]. Additional work showed the
downstream influence of this molecular switch on transcription factor FOXM1, which binds to
the MMP-7 promoter and increases transcription [159]. We propose that activation of MMP-7
in an inflammatory environment and resulting turnover of the PSPN complex, the full
proteolysis of which is described here for the first time, may activate a feed-forward loop,
increasing localized MMP-7 production and perpetuating a highly dyscohesive PCa
phenotype. One intriguing idea currently under study, supported by the aggressive metastatic
behavior of the LNCaP-RANKL cells, is that c-MET, a direct upstream regulator of FOXM1
[160], is responsible for stimulating production of MMP-7 and favoring dyscohesion. Figure
4.10 provides a model of the transition in cell phenotype that we envision occurring as a
consequence of PSPN cleavage by MMP-7. Notably, chronic activation of FOXM1 is a
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hallmark of metastatic cells [35], and FOXM1 was found to be highly active in aggressive but
not indolent PCa cells including CTCs [158].

4. Materials and Methods
4.1. Cell Culture
PCa C4-2 cell lines were cultured in 10% (v/v) heat-inactivated fetal bovine serum (FBS)
(Atlanta Biologicals S11150, Minneapolis, MN, USA) in RPMI 1640 (Gibco 22400105, Dublin,
Ireland) with 1% penicillin/streptomycin (P/S) (Gibco 15140122). Cells were passaged at 80–
90% confluency by detachment with 0.25% (w/v) trypsin 380 mg/L EDTA (Gibco 25200072)
and replating at a 1:8 seeding density. HT-29 cells were cultured in 10% (v/v) FBS and 1%
P/S in DMEM (Gibco 11965118) for passaging and expansion. Cells were maintained at 37°C
in humidified atmosphere of air:CO2 95:5 (v/v) incubator. C4-2 cells were karyotyped and
routinely monitored for mycoplasma infection and retention of PCa biomarkers. LNCaP,
LNCaP RANKL, and PC3 cells were cultured as described previously [130,154].

4.2. shRNA Treatment
C4-2 PCa cells were plated at 50% confluency in a 12-well cell culture dish in complete media.
The next day, 0.5 µL polybrene (NC9840454, stock concentration 10 mg/mL) was mixed with
1 mL of complete culture media and added to the cells. Fifteen µL of shRNA lentiviral particles
(SEMA3A – Santa Cruz sc-36470-V; plexin A1 – Santa Cruz sc-42170-V, control shRNA
(Santa Cruz - NC 9792178)) was added to each cell-containing well and allowed to incubated
for 24 hours. After 24 hours, the media was exchanged for 1 mL of complete media without
polybrene and the cells were allowed to recover for an additional 24 hours. The next day,
stable clones were selected using 3 µg/mL puromycin dihydrochloride in complete medium.
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Cells were clustered on Dm IV-3 as described previously.[161] Briefly, 1 µg heated Dm IV-3
diluted in 100 µL PBS was plated in a 96-well overnight. The next day, the Dm IV-3 solution
was removed, and a quick PBS wash was applied to the well. 10,000 cells were then added
to each well in 1% (v/v) FBS RPMI media and allowed to cluster overnight. Cells were imaged
the next day.

4.3. Perlecan Purification
FL pln was purified from the conditioned medium of HT-29 cells (formerly called WiDr) (ATCC
CCL-218, Manassas, VA, USA) as described previously [130,162]. HT-29 cells were seeded
in a hyperflask (Corning 10030, Corning, NY, USA) in 10% (v/v) FBS 1x P/S DMEM and
switched to 2% (v/v) FBS 1x P/S DMEM at nearly 100% confluence. Full media exchanges
were conducted every three days. Phenylmethylsulfonylfluoride (PSMF), benzamidine, and
EDTA at 2.5 mM each and 0.02% (w/v) sodium azide were added to collected conditioned
media and filtered through a 0.2 µm pore size PES 500 mL filter flask (Corning 431098). 500
mL of conditioned media from cells was concentrated using an Amicon Stirred Cell with a 100
kDa molecular weight cutoff filter (Millipore Sigma PBHK07610, Burlington, MA, USA). Media
was concentrated down to ~60 mL from a 500 mL collection of conditioned medium.
Concentrated conditioned medium was passed through a 30 mm diameter diethyl aminoethyl
anion exchange (DEAE) column (Cytiva 17070910, Marlborough, MA, USA). Equilibration
buffer contained 2 M urea, 50 mM HEPES, 250 mM NaCl, 2.5 mM EDTA, 0.5 mM
benzamidine, 0.5 mM PMSF, and 0.02% (w/v) sodium azide. Elution buffer was identical
except that NaCl was increased to 750 mM NaCl. A volume of 10 mL of elution buffer were
added to the column and the elution was collected in 1.5 mL fractions then absorbance read
at 280 nm. Fractions with high absorbance were pooled and buffer exchanged to MilliQ water
using centrifugal filters (Millipore Sigma Amicon UFC905008). The buffer-exchanged samples
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were subjected to size-exclusion separation by Sepharose CL-4B (Millipore Sigma CL4B200)
gel filtration chromatography in a 10 mm diameter column. Sample flow-through was collected
in 1.5 mL fractions then 10 mL of 0.8 M NaCl was added to the column and allowed to flow
through, again collected in 1.5 mL fractions. Remaining DEAE fractions and CL-4B fractions
were analyzed by dot blot immunoassay with anti-perlecan Dm I antibody A71 (Invitrogen CSI
001-71-02, Carlsbad, CA, USA). Positive perlecan fractions were pooled and dialyzed in final
PBS buffer (Millipore Sigma Amicon UFC905008). Protein concentration was determined
using the Nanodrop spectrophotometer at A280 and samples were stored as aliquots at −80
°C. Perlecan Dm IV-3 was recombinantly produced in HEK293A cells as described previously
[130].

4.4. In Silico Predictions
The amino acid sequences of plexin A1 (uniprot ID: Q9UIW2) and NRP1 (uniprot ID: O14786)
were subjected to in silico digestions using the cleavage prediction site SitePrediction [37].
Predictions were generated using information for matrix metallopeptidase-7 (Homo sapiens,
P4-P2′, 137) and default settings. The top 10 cleavage sequences are reported, all with a
specificity score of >99%. Three-dimensional predictions of protein structures were modeled
using PHYRE2 [163].

4.5. MMP-7 Digestions and Silver Stainings
Recombinant human plexin A1 (Abcam ab226422, Cambridge, MA, USA) and recombinant
human NRP1 (Novus Biologicals 3870-N1-025, Centennial, CO, USA) were subjected to
digestion by recombinant human MMP-7 (Millipore CC1059). The digestion buffer contained
10 mM HEPES buffer pH 7.0, 3 mM calcium acetate, and 1 mM EDTA. Digestions for plexin
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A1 and NRP1 contained 2 µg purified protein and 0.2 µg MMP-7. Digestions were incubated
at 37 °C for 16 h followed by heat denaturization at 100 °C in 5x Laemmli buffer for 5 min.
Denatured samples were loaded on Novex NuPAGE 10% (w/v) Bis-Tris protein gels, 1.0 mm,
10 well (Invitrogen NP0301BOX,) and electrophoresed at 150 volts with 1x MOPS buffer
(Invitrogen NP0001) for approximately 80 min. After electrophoresis, gels were stained with
Thermo Scientific™ Pierce™ Silver Stain Kit (Thermo Scientific™ 24612, Waltham, MA, USA)
according to manufacturer’s directions. Dm IV-3 and SEMA3A digestions were conducted as
described previously [130,133].

4.6. Microtumor Formation Assay
C4-2 cells were seeded at a density of 100,000 cells per well into a 24-well plate containing
750 round bottomed microwells per well (5D Spherical plate, Kugelmeiers, Zurich,
Switzerland) and allowed to form microtumors following the manufacturer’s protocol. During
microtumor formation, cells remained in RPMI without phenol red (Gibco 11835030)
containing 1% (v/v) FBS, 1% P/S at 37°C in a humidified atmosphere of air:CO2 95:5 (v/v)
incubator for 24 h. Microtumors were harvested and transferred to Dm IV-3 or FL pln-coated
wells. After a 24 h incubation period, microtumors were transferred to uncoated or rat collagen
I (R&D Systems 3440-005-01, Minneapolis, MN, USA)-coated 96-well plates and at this time
FL pln (3 µg), Dm IV-3 (4 µg), PLN4 peptide (3 µg) and MMP-7 (0.04 µg) were added to their
respective wells. The final volume was ~250 µL. PLN4 peptide was synthesized and used as
described previously [138].
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4.7. Live-Cell Imaging and Image Analysis
An A1R MP+ microscope (Ti Microscope) equipped with a Plan Apo λ 10X objective from
Nikon Instruments was used for time lapse studies of dyscohesion and migration. Brightfield
live-cell imaging was performed with a temperature-controlled heated stage at 37 °C over ~48
h and images were taken every 25 min. Images were imported into Volocity Software 6.0.1
(PerkinElmer Inc., Waltham, MA, USA) to calculate the area of cell dispersion from
microtumors at the indicated time points. To represent the total microtumor dispersion area,
the drawn perimeter consisted of spreading cells migrating out of the microtumors and free
the spaces created by migratory cells at later time points. Briefly, regions of interest at the
perimeter of spreading cells were defined using the Free Hand tool at the microtumor
periphery (yellow dotted lines in Figure 4.7) during the initial time points; and as cell dispersion
from microtumors occurred. The few cells that left microtumors as single cells were not
included in the analysis. The area values (µm2) were exported in a comma separated value
(.csv) format. Using Excel, the change fold in area was calculated by dividing spreading area
at the indicated time points by the spreading area at time 0. Change fold in area values were
analyzed using GraphPad Prism 9.0.1 software (San Diego, CA, USA).

4.8. Antibodies and Indirect Immunofluorescence
All steps were performed at room temperature unless otherwise specified. For analysis of cell
cohesion and dyscohesion, microtumors were fixed with 4% (w/v) paraformaldehyde for 20
minutes and then permeabilized with 0.3% (v/v) Triton X-100 for 30 minutes with gentle
agitation. Samples were blocked with 3% (w/v) BSA, 3% (v/v) goat serum, 0.3% (v/v) Triton
X-100 diluted in 1x PBS. Next, samples were incubated with rabbit anti-E-cadherin antibody
(1:300, Signaling, 3195S) overnight at 4 °C. Samples were washed with 1x PBS six times and
incubated with secondary antibody: 568 conjugated goat anti-rabbit (1:1000, Life
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Technologies, Carlsbad, CA, USA) and 488 conjugated phalloidin (1:100, Invitrogen) staining
overnight at 4 °C in the dark. Samples were washed four times with 1x PBS and imaged.

4.9. Proximity Ligation Assay
PLA probes were conjugated according to the DuoLink® PLA Probemaker Conjugation
Protocol at Sigma-Aldrich.com. Antibodies used for conjugation were E-cadherin (Cell
Signaling 3195S), β-catenin (BD Transduction 610153), cyclin A1 (Santa Cruz sc-271682),
neuropilin-1 (Novus AF3870), SEMA3A (Abcam 23393). Conjugated probes were stored at 4
֯C after conjugation. Treated cell clusters were fixed with 4% (v/v) PFA for 10 minutes then
washed 3 x 5 minutes with 1x PBS. Clusters were treated according to the Duolink PLA
Protocol from Sigma-Aldrich with the following modifications. Conjugated probes were diluted
in Duolink® Antibody Diluent at a ratio of 1:100 and added to cluster-containing wells.
Samples were incubated overnight at 4 ֯C. Step 3. Duolink PLA Probe Incubation was skipped,
as these probes were previously conjugated. After step 6. During the final wash, DAPI and
phalloidin 647 were add to clusters in Buffer B at a dilution ratio of 1:500 for DAPI and 1:100
for phalloidin 647 and incubated for 15 minutes at room temperature. After incubation,
samples were washed 2x with buffer B. PLA clusters were stored in 1x PBS at 4 ֯C prior to
imaging.

4.10. Image Acquisition for Indirect Immunofluorescence and Line Scan
Analysis
A1R MP+ microscope (Ti Microscope) equipped with Apo LWD 40x WI λS DIC N2 objective
from Nikon was used to image immunostained microtumors. To assess the quality of adherens
junction-based cell–cell adhesions line scan analysis on Figure 4.8 was done using Volocity
Software 6.0.1 (PerkinElmer Inc., Waltham, MA, USA).
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4.11. Enzyme-Linked Immunosorbent Assay (ELISA)
PCa cells were split and seeded at 150,000 cells per well in a 12-well plate in triplicate. Cells
were seeded in 1 mL of normal culture media as defined by the ATCC and cultured for 40 h.
Conditioned media samples were assayed using the Human Total MMP-7 Quantikine Kit
(R&D Systems DMP700) according to manufacturers’ instructions. Cells were cultured as
described above except for the LNCaP RANKL cells which were cultured without G418 for
this assay.

4.12. Statistical Analysis
For statistical analyses, GraphPad Prism 9.0.1 was used. Normalized cell dispersion areas
are shown as the mean ± SEM, with three experimental repetitions except for PLN4 peptide
plus MMP-7 which are two experimental repetitions. Two-way repeated-measures ANOVA
was used to identify interaction between different treatments and time. These tests were
followed by a post hoc Šídák’s multiple comparisons test. Results of the two-way repeatedmeasures ANOVA can be found in Supplementary Table 4.2.

5. Conclusions
In summary, this work demonstrates that a newly identified cell surface complex, the PSPN
complex, consisting of the extracellular matrix protein, perlecan, interacting with the cell
surface complex SEMA3A, plexin A1 and NRP1, plays a key functional role in cell cohesion
and dyscohesion in metastatic PCa cells. Cleavage of all components of the PSPN Complex
by MMP-7 is possible, and can activate signaling pathways that include FAK, AKT and
FOXM1, decreasing cell cohesion and increasing cell motility and dispersion. A FAKactivating peptide from a region of perlecan cleaved by MMP-7 (PLN4) additionally augments
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motility in the presence of MMP-7. While MMP-7 inhibitors previously failed in clinical trials for
treatment of metastatic disease [164–166], the findings reported here point to new avenues
to interfere with downstream activation of dyscohesion and migration resulting from MMP-7
cleavage of the PSPN Complex. This opens the door to investigation of combination therapies
with a new generation of specific MMP-7 inhibitors or inhibitors of the downstream pathways
including FOXM1.
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5. Supplementary Materials

Supplementary Figure 4.1 Analysis of PI3K-AKT pathway by PCa subtype in the Prostate Cancer
Transcriptome Atlas (PCTA) (http://www.thepcta.org/). An integrated analysis of gene expression in PCa
tissues and 8 human PC cell lines from The Cancer Cell Line Encyclopedia (CCLE) allows pathway analysis by
query. As shown in the images extracted from this database, the PI3K-AKT pathway that we found to be
activated by MMP-7 is most active in cell lines that are PCS2, including C4-2, a castrate resistant derivative
line from LNCaP, chosen for mechanistic study in this work. Panels A, C, and D represent lollipop, box, and
lineplot of mean trend values of the PI3K-AKT pathway from the database. The Z-score is a mathematically
calculated measure of the difference between the error-weighted mean of the expression values of the
genes in a gene signature and the error-weighted mean of all genes in a sample after normalization. Panel
E shows by western blot the relative levels of active pAKT that we measured in PC3 (PCS3) and C4-2 (PCS2)
cells, consistent with the database inquiry. Other commonly used cell lines (panel B) represent different
subtypes from the LNCaP series are less well suited to analysis of the proteolytic regulation of the PSPN
pathway. PCS subtypes were analyzed in reference 158.
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Supplementary Table 4.1 MMP-7 levels and PCS. MMP-7 levels (ng/mL), PCS, and clustering

Supplementary Table 4.2 Repeated Measure two-way ANOVA results (GraphPad Prism 9.0.1).

P values indicate the following:
The population means of Time are significantly different.
The population means of Treatment are significantly different.
The interaction between Time and Treatment is significantly different.
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CHAPTER 5 GENERAL
DIRECTIONS

CONCLUSIONS

AND

FUTURE

The ECM is responsible for modulating a wide range of cellular behaviors, limited not only to
migration, but also mechanical transduction, growth factor deposition and delivery, and border
structure and stability. Though many ECM molecules have long been studied, advances in
technology have allowed for the generation of large data that can be analyzed to better
understand complex ECM interactions and their context-specific influence on cellular
behaviors. The analysis done in chapter 2 focuses specifically on the core matrisome, but the
potential for this type of analysis extends far beyond what is shown here. This type of analysis
could be used in the context of matricellular or matrix-associated proteins to identify complex
interactions and context-specific expression of various enzymes or growth factors to provide
insight into potential mechanisms of action in diseases of the human body. These approaches
offer new opportunities for therapeutic intervention to prevent severe disease associated with
dysregulation of the ECM and its associated proteins as they provide new insight into potential
mechanisms of action. This dissertation focuses primarily on the epithelium and the influence
of ECM molecules on cell migratory behaviors, but we recognize the absolute value of this
type of insight in all systems of the human body, as this data is dynamic and ever-growing.

In the context of salivary gland tissue engineering, it has become increasingly important to
understand the role of the ECM and its influence on the migratory behaviors of hS/PCs, as
this lends to overall form and, ultimately, function. The collagen XVII story in chapter 3
represents an example where wet lab researchers can derive and explore information
provided by the FANTOM5 matrisome analysis and apply it in a very real sense. Extracted
salivary samples from the FANTOM5 database sorted by the most active promoters revealed
to us the importance of collagen XVII in salivary glands, particularly in the hS/PCs that our lab
87

uses. Until now, we have neglected to explore fully the complexity of salivary ECM and the
exact influence of these molecules on the ability of cells to migrate and form complex ductal
structures. As most studies of the ECM in salivary gland have been conducted in mice, the
FANTOM5 matrisome data and our unique hS/PCs allow us to look at the ECM in the context
of human biology. This chapter reveals the ability for us to assay and better predict which cells
are more likely to produce a ductal phenotype and how we might leverage that for tissue
engineering purposes. The data presented in chapter 3 demonstrates a role for the formation
of type I hemidesmosomes in the specific context of ductal formation and maintenance.
Through the collagen XVII story, we have also come to appreciate the context-specificity of
laminin 111 and laminin 332 and believe these could be essential cues to maintain functional
structures, as laminin 111 seems to be acinar-specific and laminin 332 more ductal. Knowing
this, we have begun to explore the possibility of integrating more laminin motifs, particularly
laminin 332, to better direct our salivary avatars to form complex structural units with
connected ducts and acini. In the future, I believe modulating the formation of these type I
hemidesmosomes will allow us to engineer salivary structures with intact ducts, forming
complex branched structures with functional end-bud acini.

While the work described within this dissertation is focused primarily on PCa, there are some
parallels that can be drawn to other glandular epithelium where similar complex-mediated
migration may occur. As an example, other epithelial cancers such as those of the lung,
breast, and kidney show similar metastatic behaviors, primarily in their affinity to metastasize
to bone. Perlecan and its modifiers have been implicated in these cancers, as well as
semaphorins, plexins, and neuropilins, indicating that there may be some similar mechanisms
of action that occur in these systems [136]. Through our work with PCa, we identified a novel
receptor complex that functions as a modulator of cell migratory behavior, implicating its role
in the formation of circulating tumor cells and resulting metastases. Perlecan is highly enriched
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in the TME and has been described previously for its role as a growth factor reservoir to feed
the neighboring tumor. Here, we describe a novel role for perlecan as a stabilizing scaffold for
the newly identified PSPN complex. When intact, the PSPN complex silences downstream
activation of growth and metastasis-promoting factors FAK, AKT, and FOXM1, maintaining
favored cell-cell adhesions in PCa microtumoroids. Upon cleavage of the PSPN complex by
MMP-7, downstream signaling is activated and cells become highly migratory, favoring cellsubstratum adhesions. This molecular “switch” offers a new opportunity to control the
migratory behavior of PCa cells, where traditional therapies have remained ineffective.
Previous attempts at targeting similar mechanisms of activation, such as cleavage by MMP7, have been largely ineffective in suppressing the continued growth and metastasis of PCa
tumors largely due to the significant off-target effects of such treatments. It is our belief that
combinatorial therapies may offer a novel approach to targeting these androgen-resistant
cancers, where low levels of MMP inhibitors in conjunction with a PSPN-stabilizing molecule
or FOXM1 inhibitor may be the best route for preventing secondary and tertiary metastases.
It is also interesting to consider the potential bioactivity of released PSPN complex fragments
resulting from cleavage by MMP-7. Studies have shown the presence of perlecan fragments
circulating in the sera of patients with aggressive disease, indicating their bioavailability to
cancer cells. We showed in this chapter the cell migration-enhancing effect of a 17 amino acid
peptide derived from domain IV of perlecan that we believe may be released from MMP-7
cleavage to then feed into the activation of these PCa cells. Therefore, it can be assumed that
these same cryptic peptides may exist within other members of the PSPN complex that, when
cleaved and released by MMP-7, may further enhance this migratory phenotype.

In summary, I offer a new tool to the matrix biology community to better understand the
complexity of the ECM and to identify novel interactions between ECM promoters. From this
analysis, I identified collagen XVII as a key modulator of hS/PC migratory behavior,
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specifically as it relates to the ability of cells to form complex ductal-like structures. This study
has implications in both tissue engineering applications and developmental biology of the
salivary gland, highlighting the importance of type I hemidesmosomes in salivary cell
homeostasis. In a study of PCa cell migration, I identified a novel receptor complex that acts
as a molecular “switch” to control the metastatic behavior of PCa cells. This study offers a
new mechanism for targeting highly metastatic, androgen-resistant cancers, aiming to prevent
cleavage of the PSPN complex and downstream activation of growth and metastasis factors.
All these things together represent a macroscopic view of the ECM and its application in
human glandular epithelium, to control cell migratory behaviors in applications that are
therapeutic in nature.
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CHAPTER 6 APPENDIX
Recombinant Domain III Purification
Recombinant perlecan domain III with (cxk) or without (wuy) a cystine tag was purified
following the same general protocol as other recombinant perlecan domains described
previously [167–169]. Briefly, plasmids encoding domain III and domain III + cystine knots
were purchased from VectorBuilder (VectorBuilder, IL, USA) with an EF-1α promoter and
BM40 signaling leading sequence then flanked on the end by a FLAG-tag and 6xHis-tag.
Plasmids were transfected into HEK293A cells using Lipofectamine 2000 (Life Technologies
11668030, CA, USA). Transfected cells were grown from individual cells and put under 2
mg/mL Geneticin (G418) (Teknova G5005, CA, USA) antibiotic selection. Conditioned media
was checked for domain III and domain III + cystine knots production via western blot and
probed using 6x His-tag antibody (Invitrogen MA121315, MA, USA). Positive clones were
expanded then purified and sent for sequencing to verify product. Cells were expanded and
cultured in hyperflasks (Corning 10030, NY, USA) in DMEM (Corning 10013CV, NY, USA)
2% (v/v) fetal bovine serum (FBS), 1x penicillin/streptomycin (P/S), and 1 mg/mL G418 at
~95% confluency. Full media exchanges were conducted every three days. Inhibitors
phenylmethylsulfonylfluoride (PSMF), and benzamidine at 2.5 mM each and 0.02% (w/v)
sodium azide were added to collected conditioned media and filtered through a 0.2 µm PES
filter flask (Corning 431098). All conditioned media collections were thawed and concentrated
using the Sartorius Vivaflow Cross-flow System (Sartorius, NY, USA) with Vivaflow 200
10,000 MWCO PES filters (Sartorius VP20P0). Protein was purified using a Ni-NTA agarose
resin (Thermo Fisher Scientific 88221). The column was first equilibrated with 10mM imidazole
in phosphate buffered saline (PBS), then the conditioned medium, followed by a wash of 500
mM NaCl, then washed twice with 20 mM imidazole in PBS, and finally eluted with 300 mM
imidazole in PBS. Eluted fractions were pooled and buffer exchanged with Millipore Amicon
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Ultra-15 Centrifugal Filter Units (UFC9010, Millipore Sigma, MA, USA) then aliquoted and
stored at -20 C
֯ .
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Figure 6.1 Plasmid map of Dm III with cystine knots (cxk).
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Figure 6.2 Plasmid map of Dm III without cystine knots (wuy).

94

Domain III + Cystine Knots (cxk) Sequence
5’ - GCTCCGGTGCCCGTCAGTGGGCAGAGCGCACATCGCCCACAGTCCCCGAGAAG
TTGGGGGGAGGGGTCGGCAATTGAACCGGTGCCTAGAGAAGGTGGCGCGGGGTAA
ACTGGGAAAGTGATGTCGTGTACTGGCTCCGCCTTTTTCCCGAGGGTGGGGGAGAA
CCGTATATAAGTGCAGTAGTCGCCGTGAACGTTCTTTTTCGCAACGGGTTTGCCGCC
AGAACACAGGTAAGTGCCGTGTGTGGTTCCCGCGGGCCTGGCCTCTTTACGGGTTA
TGGCCCTTGCGTGCCTTGAATTACTTCCACGCCCCTGGCTGCAGTACGTGATTCTTG
ATCCCGAGCTTCGGGTTGGAAGTGGGTGGGAGAGTTCGAGGCCTTGCGCTTAAGGA
GCCCCTTCGCCTCGTGCTTGAGTTGAGGCCTGGCCTGGGCGCTGGGGCCGCCGCG
TGCGAATCTGGTGGCACCTTCGCGCCTGTCTCGCTGCTTTCGATAAGTCTCTAGCCA
TTTAAAATTTTTGATGACCTGCTGCGACGCTTTTTTTCTGGCAAGATAGTCTTGTAAAT
GCGGGCCAAGATCTGCACACTGGTATTTCGGTTTTTGGGGCCGCGGGCGGCGACG
GGGCCCGTGCGTCCCAGCGCACATGTTCGGCGAGGCGGGGCCTGCGAGCGCGGC
CACCGAGAATCGGACGGGGGTAGTCTCAAGCTGGCCGGCCTGCTCTGGTGCCTGG
CCTCGCGCCGCCGTGTATCGCCCCGCCCTGGGCGGCAAGGCTGGCCCGGTCGGCA
CCAGTTGCGTGAGCGGAAAGATGGCCGCTTCCCGGCCCTGCTGCAGGGAGCTCAAA
ATGGAGGACGCGGCGCTCGGGAGAGCGGGCGGGTGAGTCACCCACACAAAGGAAA
AGGGCCTTTCCGTCCTCAGCCGTCGCTTCATGTGACTCCACGGAGTACCGGGCGCC
GTCCAGGCACCTCGATTAGTTCTCGAGCTTTTGGAGTACGTCGTCTTTAGGTTGGGG
GGAGGGGTTTTATGCGATGGAGTTTCCCCACACTGAGTGGGTGGAGACTGAAGTTA
GGCCAGCTTGGCACTTGATGTAATTCTCCTTGGAATTTGCCCTTTTTGAGTTTGGATC
TTGGTTCATTCTCAAGCCTCAGACAGTGGTTCAAAGTTTTTTTCTTCCATTTCAGGTGT
CGTGAGAATTAACTAGTGTTTAAACGCCACCATGAGGGCCTGGATCTTCTTTCTCCTT
TGCCTGGCCGGGAGGGCCTTGGCAGCCCCTGCTAGCGGATCTGCCCAGTTGCATG
GGGCCTCTGAGGAGCCTGGTCACTTCAGCCTGACCAACGCCGCAAGCACCCACACC
ACCAACGAGGGCATCTTCTCCCCCACGCCCGGGGAACTGGGATTCTCCTCCTTCCA
CAGACTCTTATCTGGACCCTACTTCTGGAGCCTCCCTTCACGCTTCCTGGGGGACAA
GGTGACCTCCTATGGAGGAGAGCTGCGCTTCACAGTGACCCAGAGGTCCCAGCCGG
GCTCCACACCCCTGCACGGGCAGCCGTTGGTGGTGCTGCAAGGTAACAACATCATC
CTAGAGCACCATGTGGCCCAGGAGCCCAGCCCCGGCCAGCCCAGCACCTTCATTGT
GCCTTTCCGGGAGCAAGCATGGCAGCGGCCCGATGGGCAGCCAGCCACACGGGAG
CACCTGCTGATGGCACTGGCAGGCATCGACACCCTCCTGATCCGAGCATCCTACGC
CCAGCAGCCCGCTGAGAGCAGGGTCTCTGGCATCAGCATGGACGTGGCTGTGCCC
GAGGAAACCGGCCAGGACCCCGCGCTGGAAGTGGAACAGTGCTCCTGCCCACCCG
GGTACCGTGGGCCGTCCTGCCAGGACTGTGACACAGGCTACACACGCACGCCCAGT
GGCCTCTACCTGGGTACCTGTGAACGCTGCAGCTGCCATGGCCACTCAGAGGCCTG
CGAGCCAGAAACAGGTGCCTGCCAGGGCTGCCAGCATCACACGGAGGGCCCTCGG
TGTGAGCAGTGCCAGCCAGGATACTACGGGGACGCCCAGCGGGGGACACCACAGG
ACTGCCAGCTGTGCCCCTGCTACGGAGACCCTGCTGCCGGCCAGGCTGCCCACACT
TGTTTTCTGGACACAGACGGCCACCCCACCTGTGATGCGTGCTCCCCAGGCCACAG
TGGGCGTCACTGTGAGAGGTGCGCCCCTGGCTACTATGGCAACCCCAGCCAGGGC
CAGCCATGCCAGAGAGACAGCCAGGTGCCAGGGCCCATAGGCTGCAACTGTGACC
CCCAAGGCAGCGTCAGCAGCCAGTGTGATGCTGCTGGTCAGTGCCAGTGCAAGGCC
CAGGTGGAAGGCCTCACTTGCAGCCACTGCCGGCCCCACCACTTCCACCTGAGTGC
CAGCAACCCAGACGGCTGCCTGCCCTGCTTCTGTATGGGCATCACCCAGCAGTGCG
GATCTAAGCTTGATTACAAAGACGATGACGATAAGGGATCCCACCATCACCACCATC
AC – 3’
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Domain III Without Cystine Knots (wuy) Sequence
5’ - GCTCCGGTGCCCGTCAGTGGGCAGAGCGCACATCGCCCACAGTCCCCGAGAAGTT
GGGGGGAGGGGTCGGCAATTGAACCGGTGCCTAGAGAAGGTGGCGCGGGGTAAACT
GGGAAAGTGATGTCGTGTACTGGCTCCGCCTTTTTCCCGAGGGTGGGGGAGAACCGT
ATATAAGTGCAGTAGTCGCCGTGAACGTTCTTTTTCGCAACGGGTTTGCCGCCAGAACA
CAGGTAAGTGCCGTGTGTGGTTCCCGCGGGCCTGGCCTCTTTACGGGTTATGGCCCTT
GCGTGCCTTGAATTACTTCCACGCCCCTGGCTGCAGTACGTGATTCTTGATCCCGAGC
TTCGGGTTGGAAGTGGGTGGGAGAGTTCGAGGCCTTGCGCTTAAGGAGCCCCTTCGC
CTCGTGCTTGAGTTGAGGCCTGGCCTGGGCGCTGGGGCCGCCGCGTGCGAATCTGGT
GGCACCTTCGCGCCTGTCTCGCTGCTTTCGATAAGTCTCTAGCCATTTAAAATTTTTGAT
GACCTGCTGCGACGCTTTTTTTCTGGCAAGATAGTCTTGTAAATGCGGGCCAAGATCTG
CACACTGGTATTTCGGTTTTTGGGGCCGCGGGCGGCGACGGGGCCCGTGCGTCCCAG
CGCACATGTTCGGCGAGGCGGGGCCTGCGAGCGCGGCCACCGAGAATCGGACGGGG
GTAGTCTCAAGCTGGCCGGCCTGCTCTGGTGCCTGGCCTCGCGCCGCCGTGTATCGC
CCCGCCCTGGGCGGCAAGGCTGGCCCGGTCGGCACCAGTTGCGTGAGCGGAAAGAT
GGCCGCTTCCCGGCCCTGCTGCAGGGAGCTCAAAATGGAGGACGCGGCGCTCGGGA
GAGCGGGCGGGTGAGTCACCCACACAAAGGAAAAGGGCCTTTCCGTCCTCAGCCGTC
GCTTCATGTGACTCCACGGAGTACCGGGCGCCGTCCAGGCACCTCGATTAGTTCTCGA
GCTTTTGGAGTACGTCGTCTTTAGGTTGGGGGGAGGGGTTTTATGCGATGGAGTTTCC
CCACACTGAGTGGGTGGAGACTGAAGTTAGGCCAGCTTGGCACTTGATGTAATTCTCC
TTGGAATTTGCCCTTTTTGAGTTTGGATCTTGGTTCATTCTCAAGCCTCAGACAGTGGTT
CAAAGTTTTTTTCTTCCATTTCAGGTGTCGTGAGAATTAACTAGTGTTTAAACGCCACCA
TGAGGGCCTGGATCTTCTTTCTCCTTTGCCTGGCCGGGAGGGCCTTGGCAGCCCCTG
CTAGCGGATCTGCCCAGTTGCATGGGGCCTCTGAGGAGCCTGGTCACTTCAGCCTGA
CCAACGCCGCAAGCACCCACACCACCAACGAGGGCATCTTCTCCCCCACGCCCGGGG
AACTGGGATTCTCCTCCTTCCACAGACTCTTATCTGGACCCTACTTCTGGAGCCTCCCT
TCACGCTTCCTGGGGGACAAGGTGACCTCCTATGGAGGAGAGCTGCGCTTCACAGTG
ACCCAGAGGTCCCAGCCGGGCTCCACACCCCTGCACGGGCAGCCGTTGGTGGTGCTG
CAAGGTAACAACATCATCCTAGAGCACCATGTGGCCCAGGAGCCCAGCCCCGGCCAG
CCCAGCACCTTCATTGTGCCTTTCCGGGAGCAAGCATGGCAGCGGCCCGATGGGCAG
CCAGCCACACGGGAGCACCTGCTGATGGCACTGGCAGGCATCGACACCCTCCTGATC
CGAGCATCCTACGCCCAGCAGCCCGCTGAGAGCAGGGTCTCTGGCATCAGCATGGAC
GTGGCTGTGCCCGAGGAAACCGGCCAGGACCCCGCGCTGGAAGTGGAACAGGGATC
TAAGCTTGATTACAAAGACGATGACGATAAGGGATCCCACCATCACCACCATCAC – 3’
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